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The desire to take medicine is perhaps the greatest feature  
which distinguishes man from animals. 
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Liquid chromatography (LC) with electrospray ionization (ESI) mass spectro-
metric (MS) detection has gained popularity due to its high sensitivity and se-
lectivity. LC-ESI-MS is the method of choice in many fields, like environmen-
tal and clinical analyses, proteomics, drug and doping control, and pharmacoki-
netic studies. 
ESI-MS is susceptible to the matrix effects – the alteration of signal intensity 
due to sample matrix compounds present in the ESI source. Therefore, in the 
case of complex matrices, proper sample preparation and adequate chromato-
graphic separation is required. Pharmaceuticals are often compounds with basic 
properties and for their reversed phase LC separation, acidic conditions are 
used. In acidic conditions, basic analytes are predominantly in their protonated 
(hydrophilic) form and, therefore, have poor retention on the stationary phase. 
Basic conditions for the analysis of basic compounds should provide stronger 
retention and better peak shapes. 
The ESI-MS detection dictates the volatility requirement for the eluent. The 
selection of volatile basic buffer compounds is limited and, therefore, additions 
to the buffer selection would be highly welcome. The LC-MS sets another lim-
itation to the buffer compound – the compound must not suppress the ESI-MS 
signal. Fluoroalcohols are a promising group of volatile compounds with pKa 
values suitable for the preparation of basic buffer solutions. 
The aim of the present work was to take under careful study two fluoroalco-
hols – 1,1,1,3,3,3-hexafluoro-2-propanol and 1,1,1,3,3,3-hexafluoro-2-methyl-
2-propanol and to evaluate their usage as basic LC-MS buffer components.  
In order to evaluate the novel buffer components, the influence of the fluoro-
alcohols on the ionization of analytes is studied, as well as the separation of 
several compounds of practical interest. The trends in the retention of the ana-
lytes with the change of the pH of the buffer solution are examined. Moreover, 
the retention of analytes in selected stationary phases will be examined and a 
comparison with commonly used buffer solutions is made.  
The effects of fluoroalcohols on the retention of the model compounds are 
studied and a retention model is proposed. The retention behavior of analytes on 
the reversed phase LC column in the presence of fluoroalcohol-based buffer 
solution is also compared to the retention on a fluorinated stationary phase. The 
advantages of using fluoroalcohols as LC-MS buffer components and enhance-
ments in chromatographic separation are demonstrated.  
Since the analysis would be of interest to the pharmaceutical industry, the 
successful application of fluorinated alcohols for the analysis of the pharma-





1. LITERATURE OVERVIEW 
1.1. Analysis of pharmaceuticals 
Pharmaceuticals have an extensive impact on human daily life. The behavior of 
pharmaceuticals in the human body is described by pharmacokinetics that con-
sist processes like absorption, distribution, metabolism, and excretion of the 
drug. Clinical pharmacokinetics relies on the relationship between the 
pharmacological effects of a pharmaceutical and its content in blood or plasma. 
Usually, the concentration of the pharmaceutical at its sites of action is related 
to the concentration of the pharmaceutical in the systemic circulation. Pharma-
ceutical concentration in the blood or plasma is indicating the therapeutic effect 
of the drug, either it is therapeutic, toxic (in case the dose was excessive) or if 
there is a risk for occurrence of drug concentration related adverse effects [1]. 
Pharmaceuticals used to treat human or veterinary diseases are excreted by 
humans or animals and pose a risk to the aquatic environment and soil. There-
fore, the determination of the pharmaceuticals in environmental samples is 
gaining increasingly more attention. Due to the rapid increase in the human 
population, the amount of sewage sludge and use of it has increased rapidly in 
the past two decades [2]. After composting, the sludge it can be used as a ferti-
lizer in agricultural applications [3] but only if it has been confirmed to be safe 
for the soil, surface and ground water, plants, people and animals [4]. Besides 
the heavy metals, microbes like Escherihia coli and helmints’ eggs, the content 
of pharmaceuticals, including antibiotics present in the sewage sludge are of 
interest [5]. The traces of different pharmaceuticals are found in ambient waters, 
wastewaters and drinking water [6,7]. 
In case the sludge or compost is used as a fertilizer, the pharmaceuticals and 
their metabolites could accumulate in the plants grown employing the fertilizer 
[8,9,10]. 
Approximately 75% of pharmaceuticals have basic properties. At the same 
time, about 20% are acids [11,12]. In terms of marketed drugs, about 45–50% 
are salts and the majority of these have weakly basic or weakly acidic properties 
[1]. In addition, a large scale of biologically and biomedically significant com-
pounds also have basic properties [13].  
As pharmaceuticals are often analyzed in complex matrices, elaborate sam-
ple preparation techniques and highly selective analytical methods are em-
ployed. For pharmaceutical analysis, different analytical techniques starting 
with infrared and Raman spectrometry, atomic spectrometry, capillary electro-
phoresis (CE) and liquid chromatography (LC) with different detectors – ultra-
violet/visible (UV-VIS), fluorescence (FL), mass-spectrometric (MS), electro-
chemical (EC), Corona CAD [14] detectors are used [15]. Chromatographic 
separation is one of the preferred analytical methods for the analysis of pharma-





1.2. Reversed-phase chromatographic  
analysis of basic compounds 
The high performance liquid chromatographic (HPLC) analysis of basic com-
pounds is the object of much interest especially with respect to the analysis of 
pharmaceuticals. Reversed phase (RP) chromatographic separation is one of the 
most powerful tools and has been widely used in combination with mass spec-
trometric detection. RP-HPLC allows the analysis of aqueous samples, enables 
gradient elution, and provides means for altering the retention of analytes (with 
a range of organic solvents, changes in the eluent pH and the ability to use elu-
ent additives) [16]. RP separation has disadvantages, while analytes have basic 
properties and can be advanced.  
When analyzing complex samples, e.g. environmental or biological matrices, 
chromatographic separation of pharmaceuticals from sample components is 
necessary. In RP chromatographic separation, the mobile phase is polar and the 
stationary phase surface has non-polar properties; different distribution of com-
ponents between the mobile and stationary phase provides the chromatographic 
separation of the analyte from the sample matrix. In case of neutral, i.e. less 




1.2.1. Mobile phase and buffer selection for LC-MS analysis of bases 
When analyzing ionizable compounds, the mobile phase pH can be one of the 
most important characteristics in the RP separation optimization. RP-HPLC 
analytes often contain acidic or basic functional groups and, therefore, mobile 
phases usually require pH control and buffer solution usage. While analyzing 
basic compounds, the analytes are present predominantly in their protonated 
form if the pH of the eluent is lower than the pKa value of the base. Protonated, 
i.e. the cationic form, is polar and has poor retention behavior in the RP column. 
If the pH value is higher than the pKa of the base, the basic center is deproto-
nated. As a result, better retention is expected. From this point of view, a basic 
buffer solution would be preferable for the separation of basic compounds by 
RP-HPLC. 
Another important characteristic in the selection of the mobile phase pH is 
the buffer component properties. While mass spectrometric detection (MS) is 
used as an LC detector, the volatility of buffer components is required. The use 
of non-volatile buffer components causes contamination of the electrospray 
ionization (ESI) source [17,18].LC-MS analysis combines the separation ability 
of the LC and the more sensitive and selective detection provided by the MS (or 
MS/MS) system. The selection of suitable (i.e. non-interfering with ESI ioniza-
tion) [16,19,20] buffer components in the basic pH range is limited for LC-MS 
(Table 1).  
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LC-MS with ESI has become a widely used analytical tool for the identifi-
cation and quantification of pharmaceuticals as low molecular weight 
compounds. As LC-ESI-MS is used, in addition to the volatility of the buffer 
components, these should not suppress the ESI signal. The mobile phase should 
preferably support/enhance the ionization. Due to the current selection of buffer 
components being quite poor, any addition to it would be welcome and essen-
tial.  
 
Table 1. ESI-MS compatible (volatile) buffer components recommended for Waters 
XBridge Columns at high pH by Waters® [21].  
Additive/Buffer pKa Buffer range Recommended 
concentration  
4-Methylmorpholine ~8.4 7.4–9.4 10 mM or less 
Ammonia (NH4OH) 9.2 8.2–10.2 Below 10 mM 




6.8–11.3 5–10 mM range 
Ammonium (Acetate) 9.2 8.2–10.2 1–10 mM range 
Ammonium (Formate) 9.2 8.2–10.2 1–10 mM range 
1-Methylpiperidine 10.2 9.3–11.3 1–10 mM range 
Triethylamine (as acetate salt) 10.7 9.7–11.7 0.1–1.0% range 
Pyrrolidine 11.3 10.3–12.3 – 
 
The addition of strong bases to buffers such as triethylamine (TEA) or piperi-
dine is reported to significantly suppress Na+ and K+ adduct formation while 
using MS for detection and at the same time increasing the sensitivity of elec-
trospray ionization [22]. RP-HPLC can be easily combined with ESI-MS due to 
the low ionic strength of the buffer components (usually in the range 1–10 mM) 
and organic solvent in mobile phase. The influences of several additives in LC-
MS have been studied for acidic and basic drugs. A decrease in the response 
have been demonstrated when the concentration of the additive (formic acid, 
acetic acid, trifluoroacetic acid, ammonium formate, ammonium biphosphonate, 
ammonium bicarbonate) was increased from 0.05% to 1% [23,24]. Basic buffer 
additives such as ammonium formate, ammonium biphosphonate and ammo-
nium bicarbonate have a stronger signal suppressing effect than acidic (formic 
acid, acetic acid) and basic buffers (ammonium hydroxide) for the ESI response 
of the studied acidic and basic drugs [23,24]. Also, triethylammonium acetate 
(TEAA) (Table 1) buffer solution, which can act as ion-pairing, is also known 





1.2.2. Stationary phase selection for analysis of bases  
In addition to the selection of the mobile phase buffer component and its pH, 
the second most important choice to make is a suitable stationary phase. The 
most common silica-based stationary phases are stable in the pH range 2 to 8. 
Silica-based RP column stationary phases are made by covalently bonding an 
organosilane on a silica gel surface [16]. The bonded silica has many unbound 
silanol groups on its surface and below pH 2 the bonded phase starts to hydro-
lytically cleave. Above pH 8, the silica support itself starts to dissolve. The po-
tential ionization of unbound silanol groups (–Si–OH) on the silica surface may 
occur while changes in mobile phase pH are made. [13–16] The pKa of silanol 
groups have been reported to be 4.5 [27,28], 4.9 [29], 7.1 [13], 8.5 [28] and 9 
[30].The silanol groups with a lower pKa value (around 4.5 and 4.9) are be-
lieved to belong to isolated silanol groups having no hydrogen bonding to 
neighboring groups. Other types of silanols with a higher pKa value (around 8.5) 
are connected to neighboring groups through hydrogen bonding directly or via 
bridging water molecules [29]. The surface concentration of silanols with a 
more basic pKa is higher [29]. In case of metal impurities, the acidity of silanols 
increases. When silica based columns are used within the pH range 2 to 8, the 
basic compounds are most likely in their ionized form and interactions between 
the analyte and ionized silanol groups (–Si–O–) on the stationary phase surface 
may occur. This interaction has historically been one of the most important 
causes of chromatographic peak tailing while analyzing basic compounds 
[13,31,32,33,34]. Residual silanol groups also cause low efficiency, retention 
and column-to-column reproducibility problems [13,16]. While choosing a col-
umn for application, reproducibility is an important characteristic to consider – 
especially for the routine analysis of pharmaceuticals, the column to column 
reproducibility is crucial [13]. The reproducibility problems may occur by the 
same manufacturer and the same brand, when the raw material, e.g. silica, has 
changed. Changes like these might be indicated by the manufacturer’s note 
about advanced technology. In this case, then, the reproducibility of the same 
stationary phase might be slightly different from the same stationary phase pur-
chased earlier [32].  
Nowadays, a stationary phase with the advanced purity of silica is used. Re-
sidual silanol group activities can be reduced by endcapping (a reaction of the 
bonded packing with small silane – trimethylchlorosilane, dimethylchlorosilane 
or hexamethyldisilazane) [13,16]. Some stationary phases have used endcap-
ping reagents with amino groups, which generate a considerable anion-ex-
change character [13]. Even small endcapped groups can hydrolyze from the 
packing in RP separation while a low mobile phase pH is used, for example 
after a long term operation of the column at pH < 3 [16]. 
Successful LC analysis of basic compounds can be carried out by carefully 
selecting the stationary phase with a reduced number of acidic sites and a re-
duction mobile phase pH to suppress the ionization of silanols [13,35]. Using a 
low pH decreases ion exchange interaction between the protonated base (BH+) 
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and cations that are attached to the ionized silanols on the silica surface. Si-
lanol-sample interactions can be reduced with a low mobile phase pH (between 
2 and 3.5) or a buffer solution concentration that leads to the minimization of 
ionized silanol groups. Buffer cations interact strongly with silanols and block 
sample retention on silanol sites [16]. When analytes are protonated in the solu-
tion due to the buffer solution pH but silanol groups are protonated on the sta-
tionary phase surface, better peak shapes are observed and also better ESI ioni-
zation is expected. 
However, increasing the mobile phase pH above the analyte’s pKa leads to 
the deprotonation of the basic analytes [11]. Working with basic compounds 
using the mobile phase with a high pH also sets requirements for the column. 
The selection of the column for working in a high pH range should be made 
according to its resistance to a high pH. Stationary phases with an extended pH 
range are commercially available for several applications, for example for the 
analysis of basic compounds. Basic compounds are neutral in a high pH range 
and the retention of these compounds is increased, thus allowing for better 
chromatographic optimization. Peaks of neutral compounds are more symmet-
rical in RP-HPLC separation, leading to better integration and greater resolu-
tion. A greater retention factor in the chromatographic procedure allows higher 
organic solvent content usage in the LC system mobile phase, which leads to a 
better ionization in the ESI source while using MS detection. [13,16,18] 
A wider pH range for the stationary phase allows the usage of the same an-
alytical column for different applications: the analysis of acidic compounds at a 
low pH and basic compounds at a high pH. The column selection for the appli-
cation of the basic compounds separation is a difficult task because of the wide 
variety of commercially available analytical columns. Databases, based on dif-
ferent column tests, have been created, and can help to choose the right column 
for application. Methods of column selection for basic compounds have been 
developed; for example, by Tanaka et al [36] and another is known as the 
hydrophobic subtraction procedure [37]. Nevertheless, the wide application 
range for a column is more time- and cost-effective than choosing a specific 
column for specific application.  
For the stationary phases of octadecylsilica (ODS), a wider pH range has 
been achieved by different techniques of coating the silica surface. For example, 
hybrid silica-based columns have extended the usable pH range to pH 12 (or 
higher) [34] (XBridge and BEH columns from Waters® with trifunctional lig-
and bonding chemistry or the Triart column from YMC® with multi-layered, 
organic/inorganic hybrid particles). 
 
 
1.2.3. Fluorinated stationary phases  
Another promising group of stationary phases that has been successfully applied 
in pharmaceutical and drug analysis are fluorinated (pentafluorophenyl and 
pentafluorophenylpropyl) stationary phases [38,39,40]. Fluorinated stationary 
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phases are associated with various interaction mechanisms improving retention 
and chromatographic resolution. The pentafluorophenyl stationary phase im-
proves analyte retention with dipole-dipole, aromatic pi-pi and hydrophobic 
interactions [40]. Most similar to common stationary phases are perfluorinated 
alkyl chains, for example C8, used for its alternative retention for several appli-
cations on polar molecules [41,42], especially for halogenated analytes 
[43,44,45,46], but also for aromatic polycyclic hydrocarbons due to the interac-
tions between pi-electrons and the C-F dipole on the stationary phase [45,47]. 
The performance of fluorinated columns has improved in the recent years with 
respect to their pH stability and column lifetime. Additionally, stationary phase 
bleeding is reduced allowing the use of these stationary phases also in MS ap-
plications. The retention of all analytes has been reported to be overall lower on 
the fluorinated stationary phase than on C18 [46].  
 
 
1.2.4. Hydrophilic interaction chromatography (HILIC)  
Hydrophilic interaction chromatography (HILIC) is another choice when at-
tempting the separation of hydrophilic (ionized) compounds [48]. HILIC has a 
good retention of hydrophilic compounds, lower backpressure and higher MS 
signal intensity due to the higher content of the organic solvent compared to 
RP-LC. Moreover, HILIC has been demonstrated to be efficient for the analysis 
of pharmaceutical compounds [49]. In HILIC separation, the retention mecha-
nisms are complex and different mechanisms (e.g. adsorption, ion exchange and 
hydrophobic interactions) are present at the same time for the compound ana-
lyzed [50]. Complex retention itself is different in various HILIC stationary 
phases. Retention mechanisms are influenced by the partitioning of the analyte 
molecules between the layer of water on the surface of the stationary phase and 
the amount of the organic solvent in the mobile phase, ionic retention on ion-
ized groups as well as on ionized silanols on the base silica and even the regular 
RP retention on the hydrophobic bonded ligand [13]. Due to the complex nature 
of HILIC retention mechanisms, predicting the retention of the analyte on the 
stationary phase is difficult. 
  
 
1.2.5. Fluoroalcohols as buffer components for LC-ESI-MS 
Fluorinated alcohols are volatile, weakly acidic compounds and uncharged in 
protonated form. These properties make them good candidates for LC-MS 
buffer components. Fluorinated alcohols are a potentially promising class of 
compounds to be used as weak acids for preparing buffers of pH value above 7. 
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP, pKa = 9.3) [25] has been used as 
an additive to the LC mobile phase in several studies [25,26,51,52,53,54,55,56]. 
In these studies, the pH of the mobile phase was adjusted to neutral or slightly 
basic: 7.0 [25,26,51], 7.5 [54], 7.9 [52,53], 8.2–8.4 [56] and 8.5 [55]. HFIP was 
used in these studies with triethylamine for oligonucleotide and oligosaccharide 
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analysis. As a rule, the pH range of the buffer solution should be ±1 unit of the 
buffer component’s pKa. In most of the abovementioned studies, the used buffer 
solution pH values were significantly different from the HFIP pKa. Also, HFIP 
concentrations in the studies ranged from 100 mM to 800 mM (ca 2% to 15% 
by mass), exceeding the buffer concentration levels commonly used for LC-MS 
applications (1–10 mM) by far. Thus, the role of HFIP was rather that of an 
additional solvent component than a buffer acid. Using HFIP as the weak acid 
and triethylamine (TEA) as the weak base in buffer systems resulted in high ESI 
intensities, a high efficiency of dissociation of the oligonucleotide-TEA ion-
pairs and a good chromatographic separation [25,26]. Interestingly, this promis-
ing approach of the possible usage of polyfluorinated alcohols has not been 
extended neither to the analysis of other compounds (e.g. low molecular weight 
compounds) nor to the use of other polyfluorinated alcohols (for example 
1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol (HFTB, pKa = 9.6 [57])) than HFIP. 
 
 
1.3. Retention mechanisms of reversed-phase 
chromatographic analysis  
The surface area of the stationary phase is the major factor on retention – the 
larger the surface area, the greater the retention (k). The retention factor:  
  
 =   (1) 
 
is defined through the retention time of the compound (tR) and the column dead 
time (t0). 
While only hydrophobic interactions are present, retention increases with the 
percent of carbon on a stationary phase until the organic ligands are completely 
accessible to solutes [16]. While silanol groups are present on the stationary 
phase support material surface, the RP hydrophobic mechanism might concur 
with the hydrophilic (e.g. normal phase) retention mechanism. Hydrophilic si-
lanol sites on the stationary phase surface are the cause of the hydrophilic inter-
action with analytes. In the mixed retention mechanism, the percentage of car-
bon is less significant to the retention of analytes. The general rule is that the 
retention factor (k) increases with the stationary phase surface modifier’s carbon 
chain length but is also influenced by the stationary phase surface area and the 
type of silica used in the packing material [13–18].  
A major problem of LC-ESI-MS analysis is the matrix effect [58] (discussed 
in Section 1.6). Analyte signal suppression in MS detection may occur with 
sample matrix components’ co-elution. Therefore, the chromatographic separa-
tion of analytes from matrix components can have a serious impact on detection 
sensitivity, the limits of quantitation and uncertainty. While optimizing chro-
matographic separation, the most important features after the organic modifier 
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content selection is the buffer solution component providing the separation of 
the analytes using the pH or ion-pairing effect [59].  
 
 
1.3.1. Retention of acidic and basic compounds 
In RP chromatography, hydrophobic compounds are more strongly retained on 
the stationary phase. When an acid (HA) or base (B) ionizes, the compound 
becomes more hydrophilic because its charge and retention on the stationary 
phase decreases.  
 
 ↔ +  (2) 
 + ↔  (3) 
 
While the pH is more than 2 units below the pKa of the acid, it will be mostly in 
a non-ionized form (HA). If the pH is more than 2 units above the pKa of the 
acid, the acid will be mostly in an ionized form (A–). The ionization of bases 
works the other way around, 2 units below the pKa, the base is ionized (HB
+) 
and 2 units above the pKa, the base is non-ionized (B) (Fig. 1) [16].  
 
 
Figure 1. RP-HPLC retention vs pH for acids (left) and bases (right) analysis. 
 
The non-ionized form of an analyte is more hydrophobic (less polar) and has a 
stronger interaction with the non-polar RP stationary phase, therefore the reten-
tion increases. The ionized form (A–, BH+) is hydrophilic (more polar) and 
therefore has a weak interaction with the hydrophobic RP stationary phase and 
this results in retention decreasing. While the pH is close to the pKa, a small 
change of the pH leads to a large change in retention. While routine RP-HPLC 
methods should be as robust in separation as possible, the mobile phase pH 
should be about two pKa units above or below the analyte pKa [16].  
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Retention of ionizable compounds is especially sensitive to small changes in 
the mobile phase pH. The mobile phase pH is preferably controlled by a buffer 
solution due to its ability to maintain a constant pH while a small amount of an 
acid or base is added.  
 
 
1.3.2. Ion-pairing mechanism in reversed- 
phase chromatographic analysis 
The stationary phase and mobile phase used in ion-pairing chromatography are 
similar to traditional RP chromatography phases. While ionic samples are ana-
lyzed by chromatography, ion-pairing reagents add some additional selectivity 
to the separation. The ion-pairing mechanism in RP chromatography involves 
interaction between the ion-pair reagent (cationic or anionic) and analyte and/or 
the interaction of the reagent or analyte-reagent pair with the stationary phase.  
One example is the case of the analysis of basic compounds in the proto-
nated form (BH+). Retention in ion-pairing chromatography (IPC) can be de-
scribed by two models [16]. According to one model, the ion-pairing agent 
carrying a negative charge covers the RP C18 or C8 surface by the hydrophobic 
(e.g. neutral, alkyl group) side of the agent molecule. By covering the stationary 
phase surface, the negatively charged ion-pairing agent makes the surface of the 
stationary phase more hydrophilic and covered with negatively charged groups. 
This more hydrophilic (negatively charged) stationary phase is balanced by 
positively charged ions (BH+ or Na+, allowing their exchange), thereby in-
creasing the retention of the analyte on the stationary phase. According to an-
other model, the negatively charged ion-pairing agent forms an ion-pair directly 
with the positively charged analyte, resulting in a neutral (more hydrophobic) 
anion-cation pair and increasing retention on the hydrophobic stationary phase. 




The application of the pharmaceutical analysis is demonstrated for selected 
antibiotics – sulfonamides (SAs), fluoroquinolones (FQs) and carbapenems. 
 
 
1.4.1. Sulfonamides and fluoroquinolones 
The selection of analytes for this study from the possible range of antibiotics 
was made considering the stability in the environment and the potential of the 
residues to accumulate into plants. The following five antibiotics were chosen 
for the study: three fluoroquinolones (FQs): ciprofloxacin (CIP), norfloxacin 
(NOR), ofloxacin (OFL) (Fig. 2), and two sulfonamides (SAs): sulfadimethox-
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Figure 3. Chemical structures of the used SAs.  
 
Antibiotics pathway in the environment 
Antibiotics such as FQs and SAs have many properties, facilitating their bio-
accumulation and provoking changes in the ecosystems. Antibiotics often have 
lipophilic properties in order to pass biomembranes and are persistent in order 
to avoid inactivation before having a therapeutic effect [60]. Lipophilicity is 
described by the 1-octanol/water partition coefficient (Kow). Kow is one of the 
most important parameters for estimating the environmental fate and toxicology 
of the drug and is defined as follows. 
 




where the partition of the solutes’ concentration in two immiscible liquids are 
estimated [61].  
For CIP, NOR and OFL the logKow values (at 25 °C) are 1.1, –1.4 and 0.4 
[62]. For SMX and SDM the logKow values (at 25 °C) are 0.9 and 1.6 [63].  
Antibiotics are poorly biodegraded by the bacteria present in the sewage 
sludge [64]. Using sewage sludge as a fertilizer and growing plants in this ferti-
lized soil might lead to pharmaceutical accumulation into plants. Due to the 
adsorption of antibiotics to solid sewage sludge particles and the heterogeneity 
of the sludge, the concentration of pharmaceuticals may be higher locally than 
the average in the soil [65]. Adsorption of the pharmaceuticals on soil particles 
is also described by Kow, strong adsorption on the soil particles also explains the 
slow degradation of these antibiotics in the environment [66]. In environmental 
pH conditions, the adsorption of SMX and SDM to soil clay particles was, as 
expected, to be negligible [67] while the adsorption of FQs in clay-rich soil was 
extensive. FQs appear in the soil solution partially in an anionic form. The min-
eral surface of the soil is also partly negatively charged. In the mineral surface, 
some cations are present and binding between anionic FQ molecules and the 
mineral surface will take place through the cation exchange. The adsorption of 
the FQ molecule is found to be most effective while the molecule is oriented as 
flatly as possible. The adsorption of the FQs on the soil particles is high and is 
considered to be almost 100%. Since FQs are relatively polar compounds, the 
adsorption on soil is achieved due to the cation exchange, cation bridging at 
clay surfaces, surface complexation, and hydrogen bonding [68]. Kow values 
together with the sorption coefficient and carbon-normalized sorption coeffi-
cient help to determine the nature of the hydrophobic interactions between the 
FQ and soil. The accumulated pharmaceuticals in the food plants may generate 
resistant bacteria in human and animal organisms and therefore, the environ-
mental monitoring of drugs is under careful study. 
 
FQs and SAs pKa-s  
For SMX, the pKa1 and pKa2 values are 1.49 and 5.41, and for SDM 2.11 and 
6.17, respectively [54]. The acid-base behavior of FQs has been studied by sev-
eral researchers but there is still no agreement in the published data. The num-
ber of pKa values determined for FQs is two [69], three [70] or four [71]. Also, 
the assignment of pKa values to acidic/basic sites is a topic of controversy. 
These difficulties with the studies of acid-base properties of FQs are also men-
tioned in the review article [72]. As the pH range from 9 to 10 is investigated in 
this work, only the last (most basic) pKa is of importance. Therefore, in order to 
avoid confusion, we denote this pKa as pKax. Respective acid-base equilibrium 
is presented in Fig. 3. The pKax values are adapted from the work of Barbosa et 


























Carbapenems (Fig. 5) are β-lactam antibiotics that have a broad spectrum of 
activity. Carbapenems are stable against a variety of β-lactamases. Due to the 
carbapenems’ antibacterial activity against a wide range of gram-positive and 
gram-negative bacteria, the use of these drugs is extensive. Carbapenems pene-
trate the bacterial cell wall of susceptible organisms and inhibits cell wall syn-
thesis. These drugs have been used in the treatment of serious forms of infec-
tions, for example, complicated urinary tract infections, sepses, pneumonia, 
endocarditis, and polymicrobial infections [74,75]. In the case of carbapenems, 
renal toxicity and neurotoxicity can occur (for example, imipenem has that dis-
advantage and has to be combined with cilastatin). Therefore, all modifications 
of carbapenem development should be done to decrease their toxicity. The main 
metabolites of carbapenems are inactive ring-open derivates formed by the hy-
drolysis of the β-lactam ring. Stability studies of carbapenems have also been 
the ground for extensive interest [76,77,78,79,80,81,82]. The most common 

















carboxylic acid (Fig. 6), is a broad spectrum carbapenem antibiotic for intrave-
nous administration. Meropenem is a white to pale yellow crystalline powder 
with acidic properties (pKa1 = 2.9 and pKa2 = 7.4) with the molecular weight of 
383.46 g/mol. It is effective in the treatment of Gram-negative and -positive 
infections [76,83,84]. The determination of meropenem by HPLC has been sub-
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ject to much interest. Numerous pharmacodynamic and pharmacokinetic studies 
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ene-2-carboxylic acid (Fig. 7), is a carbapenem β-lactam antimicrobial agent, 
ertapenem has antimicrobial activity against Gram-positive and -negative bac-
teria [115,116,117]. By chemical structure, ertapenem is similar to imipenem 
and meropenem [118]. Ertapenem’s pKa1, pKa2 and pKa3 values are 2.9, 6.0 and 
8.2, respectively [81]. Several pharmacodynamic and pharmacokinetic studies 















Mol. Wt.: 475,51 
Figure 7. Chemical structure of ertapenem.  
 
Imipenem, (5R,6S)-6-[(1R)-1-hydroxyethyl]-3-({2-[(iminomethyl)amino]ethyl} 
thio)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid (Fig. 8), is an off-
white, nonhygroscopic crystalline compound with the molecular weight of 
299.34 g/mol. Imipenem’s pKa1 and pKa2 values are 3.2 and 9.9 [119]. 
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Introduced first in 1980, it was the first carbapenem on the market, having a 
broad spectrum of activity against aerobic and anaerobic microorganisms, 
Gram-positive and -negative bacteria [120]. Due to the rapid degradation by the 
renal enzyme dehydropeptidase-1, imipenem is co-administered with cilastatin, 
a renal membrane dipeptidase inhibitor that increases urinary excretion of the 
active drug [120]. Cilastatin’s pKa1, pKa2 and pKa3 values are 2.0, 4.4, 9.2, 
respectively [119119]. Also, the determination of imipenem/cilastatin by HPLC 
has been of much interest. Numerous pharmacodynamic and pharmacokinetic 
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ene-2-carboxylic acid (Fig. 9) with the molecular weight of 420.50 g/mol, is a 
novel carbapenem with antibacterial activity against a wide range of Gram-pos-
itive and -negative bacteria [38, 113, 123, 124]. Being a novel carbapenem 
antibiotic drug, doripenem is stable against human renal dehydropeptidase-1 
(unlike imipenem that needs co-administration with cilastatin) [124]. Dor-
ipenem has pKa1 and pKa2 values 2.8 and 7.9, respectively [125]. The determi-
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Figure 9. Chemical structure of doripenem. 
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1.5. Preparation of biological and environmental  
samples for LC-MS analysis 
While analyzing pharmaceuticals from biological fluids for pharmacokinetic or 
pharmacodynamic studies or pharmaceutical residues from environmental sam-
ples, sample pretreatment has to be carried out.  
A number of different approaches have been used for sample preparation for 
carbapenems analysis from biological fluids. They differ widely even for the 
same matrix: e.g. solid phase extraction with different sorbents as C18 
[84,85,86,97,106,108,110], C8 [96], SCX and HLB [113] protein precipitation 
methods using methanol [97,102,121,118,122] and acetonitrile [83,110,38,109] 
or both [38], as well as column switching using Supelclean LC-NH2 40-μm (50 
x 2.1 mm i.d.) [94] and (20 x 3.9 mm i.d.) precolumn tap-filled with Li-Chro-
prep RP-8 (25–40 µm) [99] as extraction columns and filtration through syringe 
filters [88,107,112], filtered through a Nanosep 10 K instrument [124] or 
ultrafiltration [111,126] have been used for the preparation of blood plasma 
samples. 
In the case of carbapenems as relatively unstable analytes in pretreated blood 
plasma samples, a careful choice in sample preparation techniques has to be 
made according to the analyte and the time used for sample preparation and 
analysis [II].  
For environmental samples, also different sample preparation techniques are 
in use. Several extraction techniques have been applied for the determination of 
adsorbed antibiotics from a solid phase, such as ultrasonic-assisted extraction 
(USE) [127,128], microwave-assisted extraction (MAE) [129,130], pressurized 
liquid extraction (PLE), also known as accelerated solvent extraction (ASE) 
[131,132,133,134]. For the extracts’ clean-up, liquid–liquid extraction (LE) 
[135,136,137] and solid-phase extraction (SPE) [138,139,140,141] were used. 
ASE or PLE have clear advantages over other methods, such as higher preci-
sion, smaller amounts of extraction solvents and a reduced sample preparation 
time [142]. Sewage sludge extraction is usually followed by the pre-concentra-
tion and clean-up of the PLE extracts using SPE with different cartridges 
[135,132,133,134], such as C18, HLB, SCX and non-polar extractions on a 
polymeric phase. 
For the analysis of antibiotic residues from plants, LE [65,143,144] methods 
with different buffer solutions (such as disodium ethylenediaminetetraacetate 
(EDTA), citric and phosphoric, acetic acid), Soxhlet extraction [145] and for 
extract clean-up additional SPE were used with C18 [143].  
 
 
1.6. Using ESI-MS for detection 
Electrospray ionization (ESI) has become the most widely used ionization 
method for LC-MS analysis. In ESI, the analyte solution (LC eluent) is sprayed 
through a stainless steel needle. High electrical potential is applied to the ESI 
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needle with respect to the MS entrance. In this electrical field, analyte ions are 
generated and transferred into the MS.  
The formation of gas-phase ions from the solution is a multi-step process. In 
the positive ion mode, the repulsion of positive ions on the surface of the eluent 
and the pull of the electric field forms a Taylor cone at the tip of the needle 
[146]. If the electric field becomes stronger, fine charged droplets are ejected 
from the Taylor cone. The solvent evaporates from the droplets and the electro-
static repulsion at the surface of the liquid overcomes the surface tension and 
smaller charged droplets are formed [146]. The process of solvent evaporation 
and the formation of smaller droplets is repeated. Two models to describe how 
the gas-phase ions emerge from the droplets have been proposed: the ion evapo-
ration model and the charge residue model [146].  
In chromatographic separation of complex mixtures, some compounds may 
co-elute with analytes. The term matrix effect is used to illustrate the interfer-
ence of the co-eluted compounds on the ionization efficiency of the analytes. 
The change of ionization efficiency may be present also if fragmentation is used 
for quantification because the matrix effect is present already in the ionization 
source. The matrix effect can be observed also when MS/MS is used. Both sig-
nal enhancement and suppression can occur, resulting in an increase or decrease 
of the MS signal [58]. In order to evaluate the matrix effect quantitatively, the 
standard solution of the analyte in a solvent with a known concentration is ana-
lyzed with LC-ESI-MS and the peak area, Ast, is found. Also, a blank sample 
(containing all matrix compounds beside the analyte) is prepared and spiked 
with the analyte at the same concentration as the standard solution, and ana-
lyzed resulting the peak area As. The matrix effect can be estimated with the 
following formulation:  
 
 % = × 100%,  (5) 
 
When %ME value is 100%, no matrix effect is present, if %ME is below 100%, 
ionization suppression is observed and the results are underestimated. %ME 
values exceeding 100% indicate signal enhancement and the results of the 




2. AIMS OF THE STUDY 
The general objective of this work was to investigate the suitability of two 
fluoroalcohols for HPLC-ESI-MS analysis as volatile buffer compounds and, 
therefore, to increase the selection of basic buffer components for LC-MS. 
More precisely, this objective was achieved through:  
 the evaluation of HFIP and HFTB influence on ESI ionization of analytes in 
a positive and negative ESI mode 
 the investigation of HFIP and HFTB as weak acids for basic buffer solution 
components in RP chromatography, and the retention mechanisms of chro-
matographic separation 
 the comparison of HFIP and HFTB with commonly used buffer solution 
compositions in RP chromatography and to demonstrate the advantages in 
LC-ESI-MS analysis 
 the comparison of the usage of HFIP and HFTB in RP chromatographic 
separation using the C18 stationary phase with the usage of the fluorinated 
stationary phase 
 the application of the usage of fluoroalcohols for pharmaceutical analyses in 






FQs and SAs were purchased from Riedel-de-Haën (Seelze, Germany) – three 
FQs: CIP, NOR and OFL; two SAs: SDM and SMX. Meropenem from Astra-
Zeneca (United Kingdom), ertapenem, 2-tert-Butylphenol was purchased from 
Merck (Darmstadt, Germany), doripenem from AK Scientific Inc (Union City, 
CA, USA), imipenem monohydrate, HFIP, HFTB, TEA, 2,5-dinitrophenol, 
piperidine, 2-methoxypyridine, 2-methylpyridine, 2-nitroaniline, 2,3,5,6-tetra-
fluorophenol and 2,3,4,5,6-pentafluorophenol from Sigma–Aldrich (St. Louis, 
MO, USA), diethylamine, diisopropylamine from Fisher (Suwanee, GA, USA). 
3-Nitroaniline and 4-chloro-2-nitroaniline were obtained from Chemapol 
(Prague, Czech Republic). Pyrrolidine, 2-nitrophenol, 2,6-dimethylpyridine, 
ammonium acetate and 1-methylpiperidine were purchased from Fluka (Buchs, 
Germany). Acetonitrile and methanol were obtained from J. T. Baker 
(Deventer, The Netherlands), formic acid and ammonia from Riedel-de-Haën. 
All solvents were of the reagent grade or higher quality. Water was purified in-
house using a Milli-Q plus or Millipore Milli-Q Advantage A10 systems from 
Millipore (Bedford, VA, USA).  
 
 
3.2. Origin of samples and sample preparation 
3.2.1. Sewage sludge and compost [III,IV] 
The samples were taken from anaerobically digested sludge (before mixing with 
peat) in Tallinn, Estonia, and from untreated sludge (before composting with 
tree bark) in Tartu, Estonia. The sewage sludge in Tartu is treated by compost-
ing – mixing with tree bark (volume ratio 2:3). Methane fermentation and mix-
ing with peat (volume ratio 4:3) are used in Tallinn. The compost samples were 
taken from anaerobically digested sludge (before mixing with peat) in Tallinn 
and from untreated sludge (before composting) in Tartu.  
Approximately 200 g of sludge or compost (content of dry matter was 28% 
in Tallinn and 25% in Tartu) was placed into a 500 mL glass jar and mixed 
thoroughly. The jar was covered hermetically with a lid. Before analyzing, the 
samples were stored in a refrigerator at the temperature +4 °C in the dark. The 
samples were analyzed as soon as possible, usually within a week. Alterna-
tively, they were stored in polypropylene vials frozen at the temperature 
−80 °C. 
PLE was performed using an in-house designed system schematically de-
picted in Fig. 10. The extractor was designed using ultra high vacuum compo-
nents. For surviving high pressure, the stainless steel chamber cylinder wall 
thickness was 10 mm and for sealing flanges copper gaskets were used. The 
volume of the pressure chamber was 55 mL. Standard HPLC valves and stain-




Figure 10. Pressurized liquid extraction (PLE) system: A, extraction solvent; B, HPLC 
pump; C, three-way switching valve; D1 and D2, static valves; D3, the valve of argon 
gas; E, argon tank; F, oven; G, extraction cell; H, cooling coil; I, extract collection vial. 
 
9 ± 1 g (wet weight, ww) of the sewage sludge sample or compost was mixed 
1:1 with sand, and 9 ± 1 g of sample/sand blend was packed into a cellulose 
filter and placed into the extraction cell mounted in an oven. The extraction was 
performed with a 0.35% phosphoric acid and acetonitrile mixture (1:1, v/v) 
adjusted to the pH 2.50 with a 0.01 M citric acid monohydrate. For one extrac-
tion cycle, approximately 30 mL of solvent was pumped into the extraction cell 
with the static valve D1 open. The system was pressurized with argon using 
valve D3; subsequently, the cell was heated. The operating conditions were as 
follows: temperature in the range 100–110 °C with a 30 min heat-up time, pres-
sure in the range 100–110 atm (10,130–11,143 kPa), static extraction 10 min, 5 
cycles and solvent flush volume 60%. The extracted analytes were purged from 
the sample cell using pressurized argon for 40 s. The solvent used for the 
flushing of the extraction cell was collected with the static valve D2 open after 
the first cycle of extraction. Subsequent cycles of extraction were carried out 
using the same operating conditions. The extract cooling was accomplished by 
stainless steel tubing in cold water. The total volume of the extract collected 
was in the range of 150–160 mL. 
The extracts collected by PLE were cleaned up by SPE. Antibiotics such as 
CIP, NOR, OFL, SDM and SMX were extracted using SCX and HLB car-
tridges. Two different cartridges were tested with the aim of securing the best 
possible recoveries. For the SPE procedure, the vacuum manifold, supplied by 
Agilent Technologies, was used. For extraction with the SCX cartridges, the 
cartridges were preconditioned with 6 mL of methanol and 6 mL of buffer solu-
tion (1 mM ammonium acetate and 0.1% formic acid, pH 2.8). A portion 
(80 mL) of sludge or compost PLE extract was diluted to 500 mL with H2O (pH 
adjusted to 2.0) and then percolated through the cartridge at a flow rate ∼1.5 mL/min using the vacuum manifold. After extraction, the compounds 
were eluted from the cartridges using 20 mL of 20% ammonia water solution in 
40% methanol. For extraction with the HLB cartridges, the cartridges were pre-
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conditioned with 20 mL of methanol and 10 mL of Milli-Q water. The dilution 
of the PLE extract was preformed as for SCX cartridges. The flow rate of sam-
ple loading was ∼6 mL/min. After extraction, the compounds were eluted from 
the cartridges using 12 mL of methanol. The SPE extracts were concentrated on 
polypropylene vials in an N2 stream. Polypropylene vials were used to avoid the 
sorption to glass walls and samples were not evaporated to complete dryness. 
Residues were dissolved in 1 mL of 1:1 solution of methanol with a buffer so-




Aqueous solutions of the studied pharmaceuticals were mixed with soil. The 
final concentration of each pharmaceutical was 10 mg/kg (dry weight). With the 
aim of assuring the better dissolution of the studied pharmaceuticals, fluoro-
quinolones were dissolved in 2 ml of 0.1 mM ammonium acetate buffer solution 
with pH=2.8 and sulfonamides were dissolved in 2 ml of 0.3 M NaOH. The 
tubers of potato (Solanum tuberosum L), seeds of carrot (Daucus carota L), 
lettuce (Lactuca sativa L) and wheat (Triticum vulgare L) were sowed into the 
soil in the presence of five antibiotics found in the Estonian sewage sludge 
(CIP, NOR, OFL, SDM, and SMX). The plants were grown in a greenhouse 
under natural light conditions for 120 days from planting (for lettuce 70 days). 
Then, the plants were collected, dried and milled. The roots and grains were 
separated from the leaves. The milled plants were held in hermetical plastic 
bags at –80 °C. Before analysis, the samples were dried at 45 °C.  
250 mg of dried plants (grains, roots or leaves) was extracted with 10 mL of 
1:1 (v/v) mixture of acetonitrile and 1% acetic acid, then homogenized (10’) 
with the laboratory homogenizer DIAX 900 (Heidolph Instruments, Germany) 
at 25,000 rpm, sonicated (5’), vortexed (1’) and centrifuged at 8,000 rpm. The 
supernatant was then separated and dried by a nitrogen stream to remove ace-
tonitrile. Approximately 15 mL of 1 % acetic acid was added to the 1 mL of 
evaporation residue. 
The extract collected by liquid extraction was cleaned up by SPE. Antibiot-
ics – CIP, NOR, OFL, SDM and SMX – were extracted using HLB cartridges. 
For the SPE procedure, the vacuum manifold, supplied by Agilent Technolo-
gies, was used. HLB cartridges were preconditioned with 20 mL of methanol 
and 10 mL of Milli-Q water. The sample was loaded at the rate of 6 mL/min. 
After extraction, the compounds were eluted from the cartridges using 12 mL of 
methanol. The SPE extracts were concentrated in polypropylene vials in an N2 
stream. The residue was dissolved in 1 mL of 20 % methanol with a buffer so-






3.2.3. Human blood plasma and urine 
Blood samples of meropenem microanalysis  
For meropenem microanalysis, blood plasma and urine was used for the deter-
mination of meropenem. For meropenem plasma samples, 200 or 300 l of 
blood from babies with the current weight under 700 g and 700–1,500 g, re-
spectively, was drawn from an arterial cannula immediately before the drug 
administration and 2 min, 0.5, 1.5, 4, 8 and 12 h after the study dose admin-
istration [VII]. Blood was centrifuged immediately in dry vials, plasma was 
split and stored at –20 oC. At the end of the 4-hour infusion, the infusion lines 
containing meropenem solution were stored as well. Within 24 hours of collec-
tion, the samples were transferred to –70 ºC until analysis.  
 
Urine samples of meropenem microanalysis  
Urine samples were collected from a urinary catheter or with a catheter or a 
plastic bag attached to the groin region in 4-hour intervals within 12 h after the 
administration of the meropenem study dose. The quantity of the collected urine 
was measured and simultaneous possible losses were estimated by weighing the 
diapers. Urine collection was considered adequate and used for PK calculations, 
when at least 90% of the total estimated urine output for the given 4 hour period 
was collected. The samples were similarly stored immediately at –20 ºC and 
then transferred to –70 ºC [VII]. 
 
Blood samples of carbapenems analysis  
For carbapenem analysis, the blood plasma samples were collected into 4 mL 
Li-heparin vials immediately before the drug administration and 1, 1.5, 2, 2.5, 3, 
3.5, 4, 5, 6, 7 and 8 h after the study dose administration. The blood was centri-
fuged immediately, the plasma was collected and stored at –20 oC. At the end of 
the sample collection, the samples were transferred to –70 ºC until analysis. 
All sample collecting protocols were approved by the Ethics Committee of 
the University of Tartu. 
 
Sample preparation for meropenem microanalysis  
Plasma samples were melted at room temperature and 50 µL of plasma was 
transferred into a 250 µL PCR tube. Plasma samples were extracted with meth-
anol (containing ertapenem as the internal standard (I.S.) in the concentration of 
10 µg/mL): for 50 µL of plasma 50 µL of MeOH (containing ertapenem as I.S.) 
was added. After vigorous shaking with the Vortex mixer for 1 min, the sample 
was centrifuged at 8,000 rpm (3,500 x g) for 10 min and the supernatant (ap-
proximately 75 µL) was separated and filtrated through 0.22 µm Millex-GV 
PVDF filters and transferred into an HPLC autosampler vial [VII].  
Urine samples were melted at room temperature and diluted with ultrapure 
water (1/9 or more). 3 µL of the prepared sample was injected into the Agilent 




Sample preparation for carbapenems analysis  
Plasma samples were melted at room temperature and 500 µL of plasma was 
transferred into a 2 mL Eppendorf tube. Plasma samples were extracted with  
1 mL of MeCN. After vigorous shaking with the Vortex mixer for 2 min, the 
sample was centrifuged at 8,000 rpm (3,500 x g) for 10 min and the supernatant 
(approximately 1,300 µL) was transferred to another Eppendorf vial and evapo-
rated to dryness under a nitrogen stream. The residue was dissolved in 500 µL 
of MilliQ water and filtrated through 0.22 µm Millex-GV PVDF filters and 
transferred into an HPLC autosampler vial. 3 µL of the prepared sample was 
injected into the Agilent 1290 Infinity UHPLC system. 
 
 
3.2.4. Study of retention mechanisms 
Stock solutions of the analytes at 1 mg/mL in the appropriate solvent were pre-
pared. Dilutions were made and analyte concentrations ranged from 11 μg/mL 
to 145 μg/mL for working standards. Stock solutions were stored at –20 °C. 
Fresh working standard solutions were prepared daily.  
The influence of the buffer compound and pH on the chromatographic sepa-
ration was investigated. Fluoroalcohols’ interaction with the stationary phase 
surface was investigated at different eluent pH values. Nine buffer solutions: 
5 mM ammonium acetate, pH adjusted to 8.5, 9 and 10; 5 mM HFIP, pH ad-
justed to 8.5, 9 and 10; 5 mM HFTB, pH adjusted to 8.6, 9 and 10 were used. In 
all cases, the pH was adjusted using an ammonium hydroxide solution. 
 
 
3.3. LC and ESI-MS parameters 
3.3.1. Sewage sludge and compost 
The analysis of the antibiotics in the sewage sludge and compost SPE extracts 
was performed on LC–MS (Agilent Series 1100 LC-MSD Trap XCT (Santa-
Clara, CA, USA)) equipped with a binary pump, a degasser, an auto-sampler 
and a column thermostat. Antibiotics were chromatographed using a Phenom-
enex Synergi Hydro-RP column (250 mm × 4.6 mm, 4 μm) equipped with a 
Phenomenex SecurityGuard cartridge AQ 4 mm × 2 mm. Gradient elution with 
a methanol and ammonium buffer solution (1 mM ammonium acetate and 0.1% 
formic acid, pH 2.8) was used. The linear gradient with the flow rate of 0.4 
mL/min started at 35% methanol for 20 min and was raised to 80% within 20 
min, after that methanol concentration was lowered to 35% in 5 min. The col-
umn temperature was set to 30 ºC and the injection volume was 5 µL.  
For detection, the diode array detector and ESI-MS were used in series. ESI-
MS detection was carried out in the positive ion detection mode. Selected reac-
tion monitoring was used. Full MS2 spectra were recorded and the following 
transitions were applied for quantification: OFL m/z 362→ 318, 344, NOR m/z 
320→233, 276, 302, CIP m/z 332→288, 294, 314, SMX m/z 254→ 92, 108, 
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156, SDM m/z 311→108, 156, 245. Default parameters for ESI and MS were 
used for all the experiments (nebulizer gas pressure was 40 psi, dry gas flow 
was 10 L min–1, the dry gas temperature was 350 ºC, capillary voltage was 
5,000 V, the detected mass range was from m/z 100 to 1,000 and the target mass 
for compounds was m/z 350).  
 
 
3.3.2. FQs and SAs in plants 
Chromatographic separation of the analytes was carried out on the Agilent Se-
ries 1100 LC-MSD Trap XCT (Agilent Technologies, Santa-Clara, CA, the 
USA) equipped with a binary pump, a degasser, an auto-sampler and a column 
thermostat. Five antibiotics were chromatographed using a Waters XBridge C18 
column (150 mm × 3 mm, 3.5 μm) equipped with a Waters Guard Cartridge 
(20 mm × 4.6 mm) (Waters, Milford, MA, USA). For detection, the diode array 
detector and ESI-MS were used in series. ESI-MS detection was carried out in 
the positive ion detection mode. Selected reaction monitoring was used. Full 
MS2 spectra were recorded and the following transitions were applied for quan-
tification: OFL parent ion with m/z 362 [M+H]+ and product (fragment) ions 
m/z 261, 318; CIP parent ion with m/z 332 [M+H]+ and product ions m/z 288, 
314; NOR parent ion with m/z 320 [M+H]+ and product ions 302, 276; SMX 
parent ion with m/z 254 [M+H]+ and product ions m/z 108, 188; SDM parent ion 
with m/z 311 [M+H]+ and product ions m/z 108, 156, 218, 245 were detected for 
quantification. Default parameters for ESI and MS were used for all the experi-
ments (nebulizer gas pressure was 40 psi, dry gas flow 10 L/min, the dry gas 
temperature 350 ºC, capillary voltage was 5,000 V, detected mass range was 
from m/z 100 to 1,000 and the target mass for compounds was m/z 350). LC-UV 
and MS instruments were checked by Agilent Chemstation for LC 3D rev. 
A.10.02 (Agilent Technologies) and LC/MSD TrapControl ver. 5.2 (Bruker 
Daltonik GmbH, Germany). Data analysis was carried out using Chemstation 
software (Agilent Technologies) and Data Analysis for LC/MSD Trap Version 
3.2 (Bruker Daltonik GmbH).  
For elution with 5 mM, the HFIP buffer (pH adjusted with NH4OH to 9.0) 
and methanol were used. Gradient elution at the flow rate of 0.3 mL/min started 
at 10% methanol and was raised to 55% within 25 min, after that methanol con-
centration was raised to 100% within 5 min. Methanol concentration was kept at 
100% for 5 min and lowered to 10% in 5 min and was equilibrated at 10% for  




3.3.3. Carbapenems in biological fluids 
For meropenem microanalysis and the simultaneous analysis of carbapenems, 
the samples were analyzed with the Agilent 1290 Infinity UHPLC system. 
Samples were chromatographed using Waters Acquity UPLC BEH C18 column 
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(2.1 x 100 mm, 1.7 µm) equipped with Waters VanGuard Acquity UPLC BEH 
C18 Guard Column (2.1 x 5 mm, 1.7 µm) (Waters, Milford, MA, USA). Sam-
ples were analyzed with the diode array detector (DAD) at 306 nm and elec-
trospray interface Varian J320-MS Triple Quadrupole LC/MS was used for 
detection in the single reaction monitoring (SRM) mode. Parent ion [M+H]+ and 
fragment ions used for carbapenems quantification are presented in Table 2. For 
cilastatin, the parent ion with m/z 359 [M+H]+ and product (fragment) ions m/z 
202, 219, 263 and 342 were detected for quantification. For instrument control 
and data analysis, the software ChemStation for LC 3D Systems Rev. B.04.02 
[96] and Varian MS Workstation version 6.9.2 (Agilent Technologies) were 
used. Electrospray interface (ESI) was operated in the positive ion mode for 
ionization. Drying gas pressure was 12 psi (82.7 kPa) and the temperature was 
300 ºC, the capillary voltage was 5,000 V and the nebulizer gas pressure 55 psi 
(379.2 kPa). For SRM, the collision-induced dissociation (CID) gas pressure 
was 1.5 mTorr (0.2 Pa). 
 
Table 2. The optimal values for carbapenems MS detection found with optimization 
procedures for Triple Quadrupole MS.  






Imipenem 300 256 –5,5 
103 –15,5 








Ertapenem 476 432 –9 
346 –13 




1 Cilastatin is co-administered with imipenem. 
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Chromatographic conditions of meropenem microanalysis  
Gradient elution with MeOH and the buffer solution (5 mM HFIP, pH adjusted 
with NH4OH to 8.5) in water at the flow rate of 0.3 mL/min is used for chro-
matographic separation. The linear gradient started at 2% MeOH and was raised 
to 10% within 1.2 min, after 1.8 min the MeOH concentration was raised to 
33% within 1.5 min and to 80% within 0.5 min. MeOH concentration was kept 
at 80% for 1 min and raised to 100% within 0.5 min, after 0.5 min the concen-
tration of MeOH was lowered to 2% in 2 min. The column temperature was 
maintained at 40 ºC and the injection volume was 5 µL.  
 
Chromatographic conditions of carbapenem analysis  
For simultaneous analysis of carbapenems, gradient elution with MeOH and 
buffer solution (5 mM HFIP, pH adjusted with NH4OH to 10) in water at the 
flow rate of 0.3 mL/min was used for chromatographic separation. The linear 
gradient started at 2% MeOH and was raised to 10% within 2.5 min and to 15% 
within 1.5 min. MeOH concentration was kept at 15% for 3 min and raised to 
100% within 1 min and lowered to 2% within 1 min. After each chromato-
graphic run, the column stabilization (in 2% of MeOH) time was 1.5 min. Col-
umn temperature was maintained at 40 ºC and the injection volume was 3 µL.  
 
 
3.3.4. Study of retention mechanisms 
Acids and bases were chromatographed using a Waters XBridge C18 column 
(150 mm × 3 mm, 3.5 µm) equipped with a Waters Guard Cartridge (20 mm × 
4.6 mm) (Waters, Milford, MA, USA), YMC C18 column (150 mm × 3 mm,  
3 µm) (YMC Co.,Ltd., Kyoto, Japan) and silica based Epic FO-LB column (150 
mm × 3 mm, 3 µm, 120 Å) (ES Industries, West Berlin, NJ, USA). 
 
Chromatographic conditions for C18 columns  
Waters XBridge and YMC C18 stationary phases are stable in the pH range 1–
12. Mobile phases composed of different buffers, and methanol (solvent B) 
were used. Isocratic elution at the flow rate of 0.3 mL/min with 23% MeOH 
was used. The column temperature was set to 30 °C and the injection volume 
was 10 μL. The analytical column was stabilized at the flow rate 0.3 mL/min 
with 23% methanol for 100 min after the buffer solution from fluoroalcohols to 
ammonium bicarbonate or ammonium acetate was changed and for 20 min after 
each traditional buffer solution in different pHs. Stock solutions of the analytes 
at 1 mg/mL in the appropriate solvent were prepared. Dilutions were made and 
the analyte concentrations ranged from 11 μg/mL to 145 μg/mL for working 
standards. Stock solutions were stored at –20 °C. Fresh working standard solu-
tions were prepared daily. The influence of the buffer compound and pH on the 
chromatographic separation was investigated. Fluoroalcohols’ interaction with 
the stationary phase surface was investigated at different eluent pH values. 
Twelve buffer solutions: 5 mM ammonium acetate, pH adjusted to 8.5, 9 and 
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10; 5 mM ammonium bicarbonate, pH adjusted to 8.5, 9 and 10; 5 mM HFIP, 
pH adjusted to 8.5, 9 and 10; 5 mM HFTB, pH adjusted to 8.6, 9 and 10 were 
used. In all cases, the pH was adjusted using an ammonium hydroxide solution. 
 
Chromatographic conditions for Epic FO-LB column  
Epic FO-LB for pH range 1–10. Mobile phases composed of different buffers, 
and MeOH (solvent B) were used. Isocratic elution at the flow rate of 
0.3 mL/min with 23% MeOH was used. The column temperature was set to 
30 °C and the injection volume was 10 μL. The analytical column was stabi-
lized at the flow rate of 0.3 mL/min with 23% methanol for 10 min after the 
buffer solution was changed. Stock solutions of the analytes at 1 mg/mL in the 
appropriate solvent were prepared. Dilutions were made and analyte concentra-
tions ranged from 11 μg/mL to 145 μg/mL for working standards. Stock solu-
tions were stored at –20 °C. Fresh working standard solutions were prepared 
daily. The influence of the buffer compound and pH on the chromatographic 
separation was investigated. Six buffer solutions: 5 mM ammonium acetate, pH 
adjusted to 8.5, 9 and 10; 5 mM ammonium bicarbonate, pH adjusted to 8.5, 9 
and 10 were used. In all cases, the pH was adjusted using an ammonium hy-
droxide solution.  
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4. RESULTS AND DISCUSSION 
4.1. Analysis of pharmaceuticals  
LC-MS analysis of pharmaceuticals in different complex matrices has shown 
the importance of the sample preparation and clean-up procedure as well as the 
chromatographic separation in the analysis. The large variety of sample prepa-
ration methods are not effective in removing all sample components interfering 
with the analysis and causing matrix effect. Therefore, chromatographic separa-
tion has to be enhanced. The chromatographic separation of the compounds 
having similar chemical properties or simultaneous determination of many 
chemically diverse substances can be a difficult task to accomplish. For car-
bapenems or FQs having similar chemical properties (e.g. pKa values), the RP-
LC separation for simultaneous determination or separation from matrix com-
ponents is problematic [I–IV,VII]. In the next sections the sample preparation 
issues and chromatographic separation problems on carbapenem analaysis from 
the biological samples and FQs’ and SAs’ residues analysis from the sewage 
sludge and compost samples are discussed.  
 
 
4.1.1. Carbapenem analysis from biological fluids  
The sample preparation in carbapenem analysis from biological fluids [II] 
The extraction of the biological samples has to be as quick and clean as possible 
for carbapenem analysis in order to avoid analytical column contamination by 
adsorption or precipitation of blood plasma components. In carbapenem analy-
sis, the stability of the sample solution is of crucial importance [II]. The sample 
preparation and carbapenem extraction from the biological fluids have to be 
performed quickly in order to avoid the analyte’s decomposition. The sample 
preparation pH has to be controlled carefully to avoid acidic or alkaline hydrol-
ysis. A comparison of different protein precipitation techniques has been con-
ducted to estimate the suitability of the blood plasma sample preparation for 
meropenem analysis and the most efficient solvent for protein precipitation 
appeared to be MeOH [II]. For the simultaneous analysis of carbapenems, the 
recoveries of all studied antibiotics have to be taken into account. The most 
suitable (highest recoveries in the range 40–63%) and quickest sample prepara-
tion method for carbapenem analysis was protein precipitation with MeCN 
while the recoveries of the other carbapenems were lower if MeOH was used. 
When for carbapenem analysis UHPLC was used with a relatively low organic 
solvent content in the mobile phase, the large amount of MeCN in the sample 
solution caused changes in the peak shape and led to asymmetrical and tailing 
peaks. The MeCN content was lowered using the sample concentration in a 
nitrogen stream. After the concentration procedure, the samples were dissolved 
in the eluent (for the optimization of the carpabenems’ separation) several elu-
ents were used). Since in pH optimization, the eluent pH ranged from acidic to 
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PLE extraction were obtained while quartz sand was used in the extraction pro-
cedure. During PLE method development, serious carryover problems were 
observed, especially after the extraction of spiked samples. Since the PLE ex-
traction cell consists of a large metal surface, the adsorption of antibiotics onto 
the surface was extensive. Repetitive cleaning with different solvents appeared 
to be of low efficiency. For cleaning the PLE vessel, an original simple solution 
was proposed: a small amount of ethanol was burnt in the extraction vessel and 
subsequently the vessel was rinsed with the extraction solvent. The SPE method 
was optimized for FQs and SAs residues’ analysis for PLE extract clean-up and 
two types of SPE cartridges were evaluated through extraction recovery values 
[III]. In order to avoid antibiotic residues’ adsorption into the glass surface, 
polypropylene vials were used. In spite of exhaustive sample preparation of the 
sludge and compost samples, the solutions subjected to LC-MS analysis were 
still rich in matrix components.  
 
LE method for the plants  
The developed method is based on the combination of liquid extraction, SPE 
and LC-MS analysis of 5 antibiotics in total (NOR, CIP, OFL, SMX, SDM). 
The variables optimized were the extraction solvent and pH, and homogeniza-
tion. Hexane, chloroform, methanol and acetonitrile were tested as extraction 
solvents. Organic solvent content in the extraction solvent varied from 20–
100%. The pH of the aqueous component of the extraction mixture varied from 
acidic (1% acetic acid, pH 2.0) to basic (5 mM ammonium acetate, pH 9). The 
mixture of acetonitrile and 1% acetic acid (1/1) was finally chosen as an extrac-
tion solvent. Lower extraction efficiencies (recoveries of antibiotics varied from 
5 to 20%) were achieved, when 100% of acetonitrile was used as well as the 
content of acetonitrile decreased below 50%. Extraction with acetonitrile was 
more efficient compared to methanol. Extraction with chloroform and hexane 
gave overall the lowest antibiotic recoveries (1–2%) for CIP and NOR. During 
the optimization of liquid extraction, it was found that the extraction efficiency 
increased with homogenization before the sonication and mixing. The increase 
in the time of liquid extraction stages was not increasing extraction recoveries. 
In total, the time for a LE procedure was 17 minutes.  
 
SPE procedure for plant LE extract clean-up  
After the liquid extraction and centrifugation, the supernatant was separated and 
dried by a nitrogen stream to remove acetonitrile. The remaining 0.5 mL of the 
extract was cleaned up with HLB SPE cartridges. The HLB cartridges allow 
retaining both hydrophilic and hydrophobic compounds [140]. The method is 
described in Section 3.2.2. 
 
Chromatographic separation of FQs and SAs with different buffer solutions  
LC-MS analysis of FQs and SAs using the conventional C18 stationary phase 
was problematic and satisfying results were obtained with the Phenomenex 
Synergi Hydro-RP column since mass-spectrometric detection was used in the 
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selected reaction monitoring mode for detection [III,IV]. In acidic conditions, 
the CIP and NOR were still partly overlapping. Poor separation, however, can 
result in serious matrix effects. The change of chromatographic conditions as 
changing the gradient program, column temperature or change in the acidic 
buffer solution did not give satisfactory separation. Therefore, the optimization 
of the FQs and SAs separation conditions was carefully studied. A number of 
buffer solutions were assessed for their suitability for the LC-MS analysis of 
five antibiotics (Table 3) [V].  
 
Table 3. Compositions of the buffer solutions tested for the chromatographic separation 
of FQs and SAs. 
Designation Composition pH 
AAF 2.8 1 mM ammonium acetate in 0.1% formic acid 2.8 
TEAA 10.0 5 mM ammonium acetate, pH adjusted to 10.0 with 
triethylamine 
10.0 
CH3COONH4 9.0 5 mM ammonium acetate, pH adjusted to 9.0 with 
ammonia 
9.0 
CH3COONH4 10.0 5 mM ammonium acetate, pH adjusted to 10.0 with 
ammonia 
10.0 
1-MePip 9.85 5 mM 1-methylpiperidine, pH adjusted to 9.85 with 
ammonia 
9.85 
HFIP/NH4OH 9.0 5 mM HFIP, pH adjusted to 9.0 with ammonia 9.0 
HFIP/NH4OH 10.0 5 mM HFIP, pH adjusted to 10.0 with ammonia 10.0 
HFTB/NH4OH 9.0 5 mM HFTB, pH adjusted to 9.0 with ammonia 9.0 
HFTB/NH4OH 10.0 5 mM HFTB, pH adjusted to 10.0 with ammonia 10.0 
HFIP/TEA 9.0 5 mM HFIP, pH adjusted to 9.0 with triethylamine 9.0 
 
The initial separation of antibiotics was carried out using elution under acidic 
conditions with AAF 2.8 and methanol as our in-house standard method. Chro-
matographic separation of the antibiotics was problematic, the peaks of CIP, 
SMX and NOR overlapped. As the change of the organic solvent to acetonitrile 
and modification of gradient conditions did not provide better separation, the 
possibility of shifting the mobile phase pH into the basic range was taken into 
consideration. Alternatives to the basic buffer components are presented in 
Table 1. The buffer solution pH range from 9 to 10 was carefully studied and 
buffer components 1-MePip 9.85, TEAA 10.0, CH3COONH4 9.0 and 10.0 were 
selected for further study along with the novel HFIP/NH4OH and HFTB/ 
NH4OH systems. Chromatographic separation (expressed in retention times) 
ESI signal intensities in the positive and negative ion mode (expressed as peak 
heights) of analytes are presented in Table 4. 
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Table 4. Comparison of antibiotic separation and ESI signal intensity using different 
buffers. The average values for tR and signal intensities from 3 replicate experiments on 
3 different days are presented.  
     1 µg/mL 10 µg/mL 
Buffer 
solution 

















1 2.8 18.9 OFL 6.8 × 107 6.9 × 103 6.6 × 108 1.8 × 105 
19.8 *NOR 3.2 × 107 n.d. 4.0 × 108 6.6 × 104 
20.3 *CIP 4.0 × 107  n.d. 3.7 × 108 5.7 × 104 
20.3 *SMX  2.9 × 107  1.8 × 105 1.5 × 108 2.5 × 106 








5 10 12.1 SMX n.d. 7.7 × 104 n.d. 7.6 × 105 
19.6 SDM 2.1 × 105 2.1 × 105 2.1 × 106 2.2 × 106 
20.9 *NOR 4.6 × 105 1.2 × 104 4.5 × 106 1.1 × 105 
21.2 *CIP 3.6 × 105 1.5 × 104 3.6 × 106 1.4 × 105 













5 9.0 4.1 SMX 4.1 × 107 1.2 × 105 2.1 × 107 2.6 × 105 
7.5 SDM 1.5 × 107  5.2 × 105 1.4 × 108 2.0 × 106 
8.9 NOR 7.6 × 106  1.6 × 104 9.4 × 107 2.1 × 105 
10.3 CIP 1.4 × 107 1.9 × 104 2.0 × 108 3.2 × 105 











5 9.0 4.4 SMX n.d. 3.8 × 104 n.d. 3.2 × 105 
8.6 SDM 1.5 × 106 4.5 × 105 5.1 × 106 1.5 × 106 
10.8 NOR 2.8 × 106 n.d. 1.1 × 107 1.7 × 105 
12 CIP 4.8 × 106  n.d. 1.4 × 107 2.6 × 105 












5 10.0 7.8 SMX 8.8 × 105 9.5 × 104 1.9 × 107 5.0 × 105 
12.2 *SDM 5.7 × 106 1.5 × 106 1.4 × 108 3.6 × 106 
12.4 *NOR 5.6 × 106 3.1 × 104 5.1 × 107 1.5 × 105 
13.9 CIP 7.6 × 106 3.2 × 104 7.3 × 107 2.0 × 105 










0 5 9.0 7.8 SMX 2.5 × 106 1.8 × 105 1.1 × 107 5.5 × 105 
12.4 SDM 1.8 × 107 1.1 × 106 6.5 × 107 3.6 × 106 
14.8 NOR 3.7 × 106 8.0 × 103 7.7 × 107 2.2 × 105 
15.3 CIP 6.3 × 106 9.0 × 103 6.0 × 107 2.6 × 105 








5 9.85 11.3 SMX n.d. 4.7 × 104 n.d. 3.8 × 105 
16.2 SDM n.d. 3.2 × 105 5.4 × 106 2.3 × 106 
17.0 *NOR n.d. n.d. 9.2 × 104 6.5 × 104 
17.2 *CIP n.d. n.d. 4.3 × 106 2.7 × 106 
23.5 OFL n.d. n.d. 4.8 × 106 5.9 × 105 
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     1 µg/mL 10 µg/mL 
Buffer 
solution 























5 10.0 5.6 SMX 6.7 × 104 1.4 × 103 2.2 × 105 3.2 × 104 
9.8 *SDM 1.9 × 105 1.9 × 104 1.0 × 106 1.2 × 105 
10.3 *NOR 1.7 × 105 4.1 × 103 1.3 × 106 3.7 × 104 
11.6 CIP 2.5 × 105 6.3 × 103 1.1 × 106 6.4 × 104 












5 10.0 5.2 SMX 6.9 × 104 2.0 × 103 2.8 × 105 3.1 × 104 
9 SDM 3.7 × 105 1.6 × 104 1.4 × 106 9.4 × 104 
10.1 NOR 3.3 × 105 3.9 × 103 1.7 × 106 2.4 × 104 
11.3 CIP 5.4 × 105 5.5 × 103 3.9 × 106 3.8 × 104 











5 9.0 4.5 SMX 4.4 × 106 1.4 × 105 3.4 × 107 5.6 × 105 
8.2 SDM 1.8 × 107 1.2 × 106 1.6 × 108 3.8 × 106 
9.9 NOR 1.0 × 107 3.3 × 104 1.1 × 108 5.5 × 105 
11.1 CIP 1.9 × 107 5.7 × 104 2.0 × 108 6.1 × 105 











1 9.0 3.7 SMX 2.3 × 105 1.0 × 104 6.5 × 105 9.1 × 104 
6 SDM 2.5 × 105 3.7 × 104 1.7 × 106 1.6 × 105 
10 *NOR 1.3 × 105 2.1 × 103 8.2 × 105 3.5 × 104 
10.5 *CIP 1.4 × 105 3.5 × 103 1.4 × 106 5.5 × 104 











10 9.0 4.6 SMX 9.8 × 105 2.7 × 103 3.4 × 105 4.9 × 104 
8.2 SDM 2.7 × 105 1.7 × 104 1.6 × 106 2.0 × 105 
10.1 NOR 2.5 × 105 3.2 × 103 1.5 × 106 2.8 × 104 
11.6 CIP 3.1 × 105 5.5 × 103 3.1 × 106 4.8 × 104 
19.3 OFL 1.9 × 106 3.2 × 104 1.8 × 107 1.2 × 105 
* Overlapping peaks. 
 
The overlapping of some analyte peaks occurred when using 1-MePip 9.85, 
TEAA 10.0 and CH3COONH4 10.0. Satisfactory separation was achieved using 
CH3COONH4 9.0, HFIP/NH4OH 9.0 and HFTB/NH4OH 9.0. Chromatographic 





Figure 12. Chromatographic separation of five antibiotics. Used eluent buffer solutions: 
(A) AAF: 1 mM ammonium acetate and 0.1% formic acid, pH 2.8. (B) TEAA: 5 mM 
triethylammonium acetate buffer, pH 10.0. (C) CH3COONH4: 5 mM ammonium ace-
tate, pH 9.0. (D) HFIP: 5 mM hexafluoroisopropanol, pH adjusted to 9.0 with ammo-











In the case of the CH3COONH4 buffer, the retention times of SAs did not 
change with the change of the mobile phase pH from 9 to 10. This observation 
is easy to rationalize – pKa values of SAs are much lower than 9 and the change 
of pH from 9 to 10 does not cause a change in the protonation equilibrium of 
the SAs.  
When using the CH3COONH4 buffer, the retention times of FQs were 
shorter at pH 10 than at pH 9. At pH 10, the FQs exist mostly in the anionic 
form (Fig. 4) while at pH 9 some zwitterionic form is still present. Similar 
trends in the retention behavior of FQs have been noted in the pH range from 6 
to 7.5 [147] and 7.5 to 10 [69] using non ion-interaction buffer components. 
As the limit of detection (LOD) and the limit of quantitation (LOQ) are di-
rectly related to the height of the chromatographic peak rather than its area, the 
influence of the eluent composition and pH on the heights of the extracted ion 
chromatogram peaks was assessed.  
In the positive mode ESI (+ESI), the highest signals for all the analytes were 
observed using the AAF 2.8 buffer (Fig. 13). This observation can be easily 
rationalized as at pH 2.8 FQs are present as cations already in the solution 





Figure 13. Comparison of normalized signal intensities in the positive ESI mode be-







In the negative mode ESI (-ESI) at pH 2.8, the signal intensity of FQs is among 
the lowest of all (Fig. 14). FQs are in a cationic form at this pH and the conver-
sion of the solution-phase cations into gas-phase anions is not an efficient pro-
cess. For SAs, the most intense signals are observed at pH 2.8, which may be 





Figure 14. Comparison of normalized signal intensities in the negative ESI mode be-
tween different buffer compounds (n = 3). 
 
Unexpectedly, for unknown reasons CIP yields the most intense signal in  
1-MePip. 1-MePip and TEA buffers generated a background signal in the +ESI 
mode, [M+H]+ is present at m/z 100 and 102 for 1-MePip and TEA, respec-
tively. Both 1-MePip and TEA gave adduct ions with FQs. Adduct ions were 







4.2. Fluoroalcohols as buffer components for liquid 
chromatography electrospray ionization mass 
spectrometry [VI] 
4.2.1. General properties of HFIP and HFTB  
HFIP (pKa=9.3) is miscible with water, methanol, 2-propanol and hexane but is 
claimed to be immiscible with acetonitrile. Our studies showed that in the con-
centration range 1 mM to 10 mM HFIP buffer solutions with pH 9 and 10 are 
miscible with acetonitrile and can be used as buffer components for LC-MS 
analysis. When the concentration of HFIP in the buffer solution exceeded 20 
mM, then the solution appeared to be immiscible with acetonitrile. Conse-
quently, the HFIP buffer solution can be used in a mobile phase using acetoni-
trile as an organic modifier; however, in our study methanol was used because 
better separation was achieved with methanol. With methanol, gradient elution 
started at 10% of the organic component. To achieve comparable retention with 
acetonitrile, an even lower organic content proved to be necessary. However, 
the low content of the organic modifier in the eluent is not recommended for 
C18 columns due to the possibility of the stationary phase collapse. The low 




4.2.2. Ionization of HFIP and HFTB in ESI source [IV] 
For –ESI, HFIP and HFTB (pKa=9.6), buffer systems have a disadvantage: the 
background signal generated by the reagents. Fig. 15 shows the background 
spectra of the eluents with the HFIP and HFTB buffers. In the negative ESI 
mode, [M–H]– and the dimer [2M–H]– are present at m/z 167, 335 and 181, 363 
for HFIP and HFTB, respectively. HFIP and HFTB did not form adduct ions 
with analytes. Moreover, two fluoroalcohols do not have background spectra in 




Figure 15. Background spectra using HFIP and HFTB buffer components in the nega-
tive ESI mode. Flow rate 0.3 mL/min. Eluent composition 50% HFIP or HFTB buffer 
with 50% methanol. 
 
 
4.2.3. Retention of the fluoroalcohols on the stationary phase [VI] 
Fluoroalcohol retention on Waters XBridge C18 stationary phase  
To evaluate the retention of the fluoroalcohols on the stationary phase, samples 
of HFIP and HFTB were chromatographed using ammonium acetate (in pH 9 
and 10) and methanol as the eluent (Fig. 16). The logKow values for HFIP and 




Figure 16. Retention of HFIP and HFTB in –ESI mode. Eluent: 5 mM ammonium 
acetate (2nd and 4th chromatogram at pH 9 and 1st and 3rd chromatogram at pH 10) 
and MeOH (77/23). Used analytical column: Waters XBridge C18 column 
(150 mm × 3 mm, 3.5 μm). 
 
The retention times of HFIP were 34 and 21 min (with the retention factor k 8.4 
and 4.8) at pH 9 and 10, respectively. The retention times of HFTB were 87 and 
64 min (with k 23.2 and 16.8) at pH 9 and 10, respectively. HFIP and HFTB 
concentration in injected solutions ranged 20–60 mM and the injection solvent 
contained 23% of methanol. The retention factors indicate that the retention of 
fluoroalcohols differs significantly at different mobile phase pH values being 
greater at a lower pH.  
Chromatograms in Fig. 16 are extracted ion chromatograms in the –ESI 
mode, the poor peak shape and noisiness of the peaks is related to the high con-
centration of the fluoroalcohol in the injected solution and the low ionization 
efficiency of fluoroalcohols in the –ESI mode.  
Differently from acetate-containing buffers in the case of fluoroalcohols, a 
significant fraction of the alcohol is in the neutral form at all used pH values. 
The fluoroalkyl moiety of the fluoroalcohols is appreciably hydrophobic and 
interacts with the RP stationary phase. The fluoroalcohols alter the original sta-
tionary phase by forming a separate relatively low polarity and rather acidic 
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“fluorous phase” on the stationary phase surface, which has a higher volume at 
a lower pH. 
 
 
4.3. Ionization of analytes from solutions containing 
fluoroalcohols [V] 
For the estimation of fluoroalcohol buffers’ influence on the analytes’ ioniza-
tion the SAs and FQs were used (see Section 4.1.2.). Buffer systems of a weak 
acid (HFIP) and a weak base (TEA) were compared with fluoroalcohol/NH4OH 
buffers at pH 9 and 10. Separation was achieved using HFIP/TEA at pH 9, but 
very low ESI-MS signal intensities were observed and analytes remained unde-
tected at 1 µg/mL level 
When considering the basic pH range, HFIP/NH4OH 9.0 and HFTB/NH4OH 
9.0 provide equally high signal intensities for all the analytes.  
Very low analyte signal intensities were observed for 1-MePip and buffers 
containing TEA: SMX was not detected using HFIP/TEA 9.0 buffer, none of 
the five analytes were detected at 1 g/ml concentration level with 1-MePip 
9.85. In contrast to CH3COONH4 9.0 and 10.0 buffers, using which comparable 
signal intensities for all the analytes were obtained, HFIP/NH4OH and 
HFTB/NH4OH cause very low signal intensities at pH 10 (Fig. 13). In the posi-
tive ESI mode no interfering ions were observed.  
In the basic buffers NOR, OFL and SDM exhibit the most intense signals in 
the HFIP/NH4OH 9.0 buffer and SMX in the HFTB/NH4OH 9.0. The weakest 
signals were observed in the case of HFIP/NH4OH 10.0 and HFTB/NH4OH 
10.0 as was the case in +ESI. 
The use of HFIP and HFTB buffer systems enhancing signal intensities was 
registered in the positive as well as negative ESI mode (even though HFIP and 
HFTB contributed to background spectra in a negative mode) in the analysis of 
FQs and SAs. On the side of the ionization the influence of the fluoroalcohols 
on chromatographic separation of the analtyes was studied.  
 
 
4.4. Chromatographic separation of FQs and SAs on C18 
stationary phase using eluents containing  
fluoroalcohol-based buffer solutions [V] 
Results discussed below are shown in Table 4. Using HFIP/NH4OH and 
HFTB/NH4OH buffers, SAs’ retention times were shorter at pH 9. This change 
of retention times must be caused by the nature of HFIP and HFTB. HFIP and 
HFTB are predominantly protonated at pH 9 and are predominantly deproto-
nated at pH 10, e.g. at pH 9 they are less polar than at pH 10. Therefore, at pH 9 
the fluoroalcohols effectively compete with the analytes for the stationary phase 
surface, which is indicated by the shorter retention times of SAs at pH 9. At pH 
9 as well as pH 10, retention times of SAs are longer in the case of 
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CH3COONH4 as compared to HFIP and HFTB. This also indicates that the 
fluoroalcohols compete with analyte molecules for the stationary phase surface.  
In the case of the HFTB/NH4OH buffer, the retention times of FQs increased 
with the increase in pH. This is contrary to the effect observed in the case of the 
CH3COONH4 buffer. In the case of the HFIP/NH4OH buffer, retention times of 
FQs were nearly the same at pH 9 and 10. The pH of a solvent has a similar 
effect on the solute regardless of the compounds used to create the pH, e.g. CIP 
is protonated to the same extent in the CH3COONH4 9 as in the HFTB/NH4OH 
9 buffer. However, these pH values refer to the buffer solution before mixing 
with the organic solvent. The addition of the organic solvent may have a differ-
ent effect on the buffer solutions created by using different acid-base systems. 
In the CH3COONH4 buffer solution, ammonia acts as the weak base, while ace-
tic acid is virtually fully deprotonated. In the HFTB/NH4OH and HFIP/NH4OH 
buffer solutions, both compounds are present as mixtures of protonated and 
deprotonated form but at different ratios. Thus, the effective pH in the eventual 
mobile phase can be different in all three cases. Further effects to consider are 
the competition of the alcohols for the active sites of the stationary phase and 
the complex acid-base behavior of the FQs (present partly as zwitterions at the 
used pH level) which, in turn, also depends on the organic solvent. The ob-
served retention time changes are probably due to a complex interplay of all 
these effects. 
During the separations with the TEAA and HFIP/TEA buffers, TEA ions can 
form ion-pairs with FQs deprotonated carboxyl groups and SAs sulfonamide 
groups and the retention of antibiotics increases. Retention increase is more 
significant for the TEAA buffer. Retention increased using the HFIP/TEA 
buffer compared to the HFIP/NH4OH buffer due to the analyte ion-pairing 
effect with TEA. Using ammonium hydroxide as an additive for the buffer so-
lution, the ion-pair formation between the negatively charged antibiotics and 
ammonium ion does not alter retention times to a significant extent. 
 
 
4.5. Study of retention mechanisms of analytes on  
C18 stationary phase using eluents containing 
fluoroalcohol-based buffer solutions [VI] 
The retention mechanisms using HFIP and HFTB as buffer acids were studied. 
Since FQs and SAs are chemically complex compounds for estimating the re-
tention mechanism’s nature in fluoroalcohol usage, simpler compounds were 
selected for the study. The selection of analytes for the present study was made 
based on their pKa values – acids and bases with a pKa below 7 and above 10 
(i.e. outside the 8.5–10 region) were studied. The effect of the pH and the com-
position of the buffer solution on the retention of 15 compounds (see Table 5) 




Table 5. Analytes for the present study – acids and bases with pKa values below 7.2 and 
above 10.2. The values of logKow are taken from LOGKOW© database [148].  
Acids, pKa >10.2 
HA 
Acids, pKa <7.2, A
– Bases, pKa <7, B Bases, pKa >11, BH
+ 
2-tertbuthylphenol 
pKa = 10.28 
logKow = 3.31 
2,5-dinitrophenol 
pKa = 5.15 
logKow = 1.54 
2,6-dimethyl-
pyridine 
pKa = 6.65 
logKow = 1.68 
Pyrrolidine 
pKa = 11.27 
logKow = 0.46 
2-nitroaniline 
pKa = 17.9 
logKow = 1.85 
2-nitrophenol 
pKa = 7.17 
logKow = 1.77 
2-methylpyridine 
pKa = 5.97 
logKow = 1.11 
Diethylamine 
pKa = 11.02 




logKow = 1.43 
2,3,5,6-tetrafluoro-
phenol2 
pKa = 5.53 
logKow = 2.84 
2-methoxypyridine 
pKa = 6.47 
logKow = 1.36 
Piperidine 
pKa = 11.12 
logKow = 0.84 
4-chloro-2-nitro-
aniline 
pKa = 17.1 
logKow = 2.72 
2,3,4,5,6-penta-
fluorophenol3 
pKa = 5.41 
logKow = 2.65 
 Diisopropylamine 
pKa = 11.05 
logKow = 1.40 
1 pKa is estimated using the COSMO-RS approach as described in Ref. [149] 
2–3 logKow is calculated using the ALOGPS 2.1 approach. 
 
 
4.5.1. Comparison of analytes’ retention in case of fluoroalcohols and 
ammonium acetate buffers [VI] 
As demonstrated in section 4.2.3, fluoroalcohols are strongly retained on the 
C18 stationary phase. If present in the mobile phase, fluoroalcohols form a dy-
namic layer on the C18 stationary phase. This formed phase is less attractive for 
the acidic analytes than the native RP phase. In fact, fluoroalcohols compete 
with acidic analytes for the stationary phase surface and thus their retention 
times are shorter than when using ammonium acetate with the same pH  
(Fig. 18). The competition over the stationary phase was stronger for 
deprotonated acids (A−, pKa below 7.2). For the highly basic and non-polar 
analytes, this “fluorous phase” is more attractive because of the formation of 
hydrogen bonds with the fluoroalcohols. This leads to higher retention times for 





Figure 17. Retention times (n = 3) of protonated bases, BH+-pyrrolidine, diethylamine, 
piperidine and diisopropylamine, using ammonium acetate, HFIP and HFTB buffers in 
the pH range 8.5–10. The column dead time was 3.6 min. 
 
 
Figure 18. Retention times (n = 3) of deprotonated acids A−-2,3,4,5,6-pentafluorophe-
nol, 2,3,5,6-tetrafluorophenol, 2,5-dinitrophenol and 2-nitrophenol, using ammonium 





For neutral analytes-protonated acids, AH (acids with pKa > 10), and deproto-
nated bases, B (bases with pKa < 7), the retention time differences between am-
monium acetate and fluoroalcohol buffers were not significant (Fig. 19). 
 
 
Figure 19. Retention times (n = 3) of the protonated acid, AH-3-nitroaniline and 
deprotonated base B-2-methylpyridine, using ammonium acetate, HFIP and HFTB 
buffers in the pH range 8.5–10. The column dead time was 3.6 min. 
 
 
4.5.2. Comparison of analytes’ retention at different  
pH values of fluoroalcohol buffers 
With an increase in the eluent pH, the interaction between the stationary phase 
and fluoroalcohol decreases since the content of deprotonated fluoroalcohol 
increases. Fluoroalcohols have a weaker interaction with the stationary phase at 
pH 10, as their deprotonated forms are more hydrophilic and spend a relatively 
longer time in the mobile phase compared to pH 8.5, where the protonated form 
dominates. This concept is clear from the chromatograms in Fig. 16, where 
fluoroalcohols have shorter retention times at pH 10 as compared to a lower pH. 
As a result, the retention times of the acidic analytes should be shorter at pH 8.5 
than at pH 10 due to the competition between fluoroalcohols and analytes for 
the stationary phase surface. Analyte retention times were indeed shorter for 
acids having pKa values below 7.2 (Fig. 19). 2,5-Dinitrophenol retention time 
was 2.9 min shorter using HFIP at pH 8.5 than at pH 10 (k 0.69 and 1.5, respec-
tively) and 2.8 min shorter using HFTB at the same pH (k 0.16 and 0.94, re-
spectively). 2,3,5,6-Tetrafluorophenol and 2,3,4,5,6-pentafluorophenol retention 
times were 2–5 min shorter using HFIP and HFTB at pH 8.5 (8.6 for HFTB) 
comparing with retention using the same buffer solutions at pH 10. Judged by 
the retention factors, the competition with the fluoroalcohols is very strong, 
especially in the case of HFTB. 
However, 2-nitrophenol is an exception – its retention time does not change 
significantly in the used pH range (Fig. 19). However, this acid is weaker than 
the others and even in water its pKa value is not far from the mobile phase’s pH 
range. In the used mobile phase, its pKa value is expected to be around 0.5 pKa 
units higher than in water [150]. At the same time, the pKa value of protonated 
ammonia is around 0.3 pKa units lower than in water [150]. This means that in 
the mobile phase with the pH 8.5, this compound is present to a large extent as 
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neutral and this elongates its retention time and removes the pattern seen with 
stronger acids. 
From the chromatograms in Fig. 16, it is also evident that HFTB interacts 
with the stationary phase surface more strongly than HFIP. Therefore, shorter 
retention times of analytes using HFTB as compared to HFIP would be ex-
pected. HA, A− and B compounds had shorter retention times using an HFTB 
buffer comparing with an HFIP buffer. The only exception is 2-methylpyridine, 
deprotonated base B, having comparable retention times in both mobile phases.  
 
 
4.5.2. Effect of the acid-base equilibria on retention time 
The pH-dependence of retention of acidic and basic analytes is usually inter-
preted by means of the acid-base equilibria of analytes. In the case of fluoro-
alcohols as buffer components, this approach is not able to account for all the 
observed effects. Therefore, additionally, buffer components’ retention on the 
stationary phase and thus modifying the stationary phase properties, as well as 
ion-pairing effects are involved in the discussion below. 
Adding methanol to the buffer solution changes all the pKa values involved. 
Thus, both pH and the ionization ratios of the analytes are different in the actual 
mobile phase. Furthermore, the pKa values of neutral acids are generally more 
sensitive to changes in solvent composition than pKa values of protonated bases. 
The discussion presented in this section ignores this effect. However, we have 
two reasons to expect that with the used mobile phase this effect is minimal:  
(1) we use methanol – a protic solvent – as the organic modifier and (2) the 
content of methanol in the mobile phase is low. 
RP-HPLC retention is strongly dependent on compounds’ hydrophobicity as 
the retention increases for more hydrophobic compounds. Acids exist predomi-
nantly in their deprotonated form (ionic, i.e. polar) at pH values higher than the 
pKa of the acid. Bases at pH values lower than their pKa value exist predomi-
nantly in their protonated (ionic, i.e. polar) form. Retention times of the ionic 
forms of acids and bases are shorter than those of the respective neutral (less 
polar) forms [16]. In the case of the ammonium acetate buffer, upon increasing 
pH from 8.5 to 10, the retention times of the protonated bases (BH+, pKa above 
11) increase as the fraction of analyte in deprotonated (neutral, B) form in-
creases (Fig. 17).  
Protonated bases, BH+ had shorter retention times with an ammonium ace-
tate buffer compared to fluoroalcohols and shorter retention times using an 
HFIP buffer than using an HFTB buffer at the same pH (Fig. 17). 
Out of the acids existing in the mobile phase predominantly in a deproto-
nated form, the A− (pKa below 7.2) retention time decreased for 2-nitrophenol 
(pKa 7.17) as closest to the pH range of the buffer solutions because the propor-
tion of the deprotonated form (anion, A−) predominates at a higher pH (Fig. 18). 
Deprotonated acids, A− (acids with pKa < 7.2), had longer retention times 
using ammonium acetate compared to fluoroalcohols (over 10 min longer for 
57 
 
2,3,4,5,6-pentafluorophenol, 2,3,5,6-tetrafluorophenol and 2,5-dinitrophenol 
and 3–5 min longer for 2-nitrophenol). Deprotonated acids had stronger reten-
tion using an HFIP buffer compared to an HFTB buffer at the same pH. The 
retention time difference was bigger for 2,3,4,5,6-pentafluorophenol, 2,3,5,6-
Tetrafluorophenol and 2,5-dinitrophenol (Fig. 18).  
Retention times of the stronger acids did not decrease with increasing pH as 
their pKa values were sufficiently low to regard these compounds completely 
dissociated in the whole studied pH range. 
Very weakly acidic (pKa > 10) and very weakly basic (pKa < 7) analytes, 
which are in a neutral form at the used pHs, were included in the study for the 
comparison of retention with acidic and basic analytes. For protonated acids 
(HA, pKa above 10), the mobile phase pH did not have a strong influence on the 
retention time as compounds were in the mobile phase in their protonated form 
(Fig. 19). 
For deprotonated bases (B, pKa below 7), the retention time decreased with 
the pH increase (Fig. 19). This is the opposite to what is predicted by theory, 
but this is easily explained by the difference of the ionic strengths of the ammo-
nium acetate buffers: more ammonium hydroxide solution was required to ob-
tain buffer solutions with a higher pH. 
 
 
4.5.4. Ion-pairing mechanisms 
Retention of BH+ compounds (protonated bases) cannot be explained using the 
above proposed model of altered stationary phase surface as their retention 
times using the HFTB buffer are longer than with the HFIP buffer at the same 
pH (Fig. 17). Ion-pairing mechanism is needed to account for this observation. 
Retention in IPC can be described by two models described on Section 1.3.2. 
If we apply the first model to fluoroalcohols as ion-pairing reagents, then the 
stationary phase will be covered with anionic moieties of the fluoroalcohols. 
The negatively charged stationary phase is balanced by positive ions from the 
buffer and/or analyte. Positively charged analytes (BH+) can exchange cations 
from the balancing layer. In accordance with this model, retention times for 
protonated bases (cations, BH+) using fluoroalcohols are longer than when us-
ing ammonium acetate (Fig. 18). For the neutral compounds HA and B, the 
retention times were similar between fluoroalcohols and ammonium acetate 
(Fig. 19). Retention times for deprotonated acids (anions, A−) are shorter with 
fluoroalcohol buffers, comparing with ammonium acetate due to the distraction 
between the analyte anions and fluoroalcohol anions in the stationary phase 
(Fig. 18.). 
At pH 10, fluoroalcohols are ionized to a larger extent than at pH 8.5 (8.6 for 
HFTB). Consequently, cation (BH+) retention times should be longer at pH 10. 
Retention time is indeed approximately 3 min longer for diisopropylamine 
(protonated base) at pH 10 (Fig. 17). Anion (A−) retention times should be 
shorter at pH 10 than at pH 8.5 (Fig. 18). However, the opposite is observed 
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(except with 2-nitrophenol). Thus, the first ion-pairing model is not fully in line 
with the experimental data.  
HFTB is a less polar compound and ion-pairs between its anion and a proto-
nated base have a stronger interaction with the stationary phase surface than 
HFIP. Thus, the retention times of protonated bases (Fig. 17) are longer when 
HFTB is used (compared to HFIP). 
 
 
4.5.5. Ion interaction and competition for stationary phase surface 
The dependence of the retention of protonated bases on the pH in the case of 
HFIP- and HFTB-containing mobile phases cannot be explained by either ion-
pairing of fluoroalcohol deposition on the stationary phase mechanism alone. 
The retention behavior can only be rationalized by considering that these mech-
anisms are both active and at a different pH, a different mechanism dominates. 
At pH 10, the cations are retained predominantly by the ion-pairing mecha-
nism. At pH 8.5, retention is mainly controlled by the interaction with the 
“fluorous phase” formed by HFIP or HFTB. At pH 9, both these interactions are 
somewhat weakened and the retention is weaker (Fig. 17) 
 
 
4.6. Retention on two C18 stationary phases using 
fluoroalcohol-based buffers  
For HFIP and HFTB evaluation retention on another C18 stationary phase, 
YMC-Triart C18 was studied (referred to as Triart in the following text). The 
stationary phase of the Triart column is of higher hydrophobicity than XBridge 
(a Waters XBridge C18 column). The hydrogen bonding capacity is similar for 
the two stationary phases [151]. The analytes employed in the study are pre-
sented in Table 5 and chromatographic conditions are presented on the Section 
3.3.4. 
Due to the higher hydrophobicity, the retention of all analytes studied was 
stronger on the Triart column (Fig. 20). The trends of all analytes’ retention on 
Triart were similar to XBridge when ammonium acetate, ammonium bicar-
bonate and fluorinated alcohol buffers were used. Therefore, only representative 





Figure 20. Retention comparison (n = 3) between two C18 stationary phases using an 
HFTB buffer on the pH range from 8.6 to 10 with XBridge and Triart for analytes: A–- 
2,3,4,5,6-pentafluorophenol, B-2-methylpyridine, AH- 3-nitroaniline and BH+– diethyl-
amine. The column dead times were 3.6 and 2.1 min for XBridge and YMC, respec-
tively. 
 
On both stationary phases, the retention of deprotonated acids (A–) increased 
with the increase of pH using fluorinated alcohols for elution (Fig. 20). Depro-
tonated acids’ competition over the stationary phase surface has the strongest 
effect on the retention behavior (Section 4.5.2). 
The retention of neutral compounds had interesting trends on the Triart col-
umn, for the deprotonated bases (B) the retention behavior was bell-shaped and 
for the protonated acids (AH) the retention increased with the increase of the 
mobile phase pH. Both competition over the stationary phase surface and ionic 
strength of the buffer are responsible for the retention behavior of neutral com-
pounds. 
In case of protonated bases (BH+), the increase in eluent pH caused retention 
time’s increase on Triart and a reduction on XBridge (Fig. 20). At pH 8.6, 
fluoroalcohol is predominantly in the neutral form, therefore no ion-pair for-
mation with the analyte is expected and retention is controlled by the competi-
tion over the stationary phase surface. As Triart is more hydrophobic, it inter-
acts more strongly with fluoroalcohol and, therefore, retention is shorter than on 
XBridge. At pH 10 fluoroalcohol is in a deprotonated, anionic form and can 
form ion-pairs with the analyte. Owing to higher hydrophobicity, retention 
times are longer on Triart. 
The comparison of retention on columns with different hydrophobicities 





4.7. Retention of acids and bases on  
fluorinated stationary phase  
For the alternative retention mechanisms the fluorinated stationary phase was 
involved to the study. The fluorinated stationary phases are known for suffering 
under poor column lifetimes, the unstable baseline while MS is in use for de-
tection. The improvements of fluorinated stationary phases are made to lead 
them for MS capability. Fluorinated stationary phases are a class of promising 
tools for the separation of pharmaceuticals due to the ability of providing alter-
native retention mechanisms for the improvement of retention and chromato-
graphic resolution. The ESI ionization of analytes (FQs and SAs) in acidic con-
ditions was better and, therefore, the alkyl perfluorinated stationary phase was 
studied for analytes’ separation on acidic buffer conditions (Section 4.8.2.). In 
order to compare separation provided by fluorinated alcohols with the commer-
cially available fluorinated stationary phase, the same compounds – acids and 
bases from Table 5 – and the Epic FO-LB as alkyl perfluorinated C8 were in-
volved in the study.  
 
 
4.7.1. Comparison of analytes’ retention of fluorinated stationary 
phase at different pH values of commonly used buffers 
The retention of protonated bases (BH+, pKa above 11) on alkyl perfluorinated 
C8 with ammonium acetate and ammonium bicarbonate is presented in Fig. 21. 
In the case of the ammonium acetate and ammonium bicarbonate buffer, upon 
increasing pH from 8.5 to 10, the retention times of protonated bases increase as 
the fraction of analyte in the deprotonated (neutral, B) form increases (Fig. 21). 
An exception was pyrrolidine – while at pH 9, the retention of the compound 
was the strongest with the ammonium acetate and ammonium bicarbonate 
buffer (k were 4.9 and 5.3, respectively). Ammonium acetate and ammonium 





Figure 21. Retention times (n = 3) of protonated bases, BH+-pyrrolidine, diethylamine, 
piperidine and diisopropylamine, using ammonium acetate and ammonium bicarbonate 
buffers in the pH range 8.5–10 with Epic FO-LB column. The column dead time was 
1.2 min. 
 
The retention time of deprotonated acids, A− (pKa below 7.2) retention on alkyl 
perfluorinated C8 using ammonium acetate and ammonium bicarbonate de-
creased with the increase of the buffer solution pH. The effect on retention de-
crease was the strongest for 2-nitrophenol (pKa 7.17, as closest to the pH range 
of the buffer solutions) because the proportion of the deprotonated form (anion, 
A−) predominates at a higher pH (Fig. 22). The difference in retention times 







Figure 22. Retention times (n = 3) of deprotonated acids A−-2,3,4,5,6-pentafluorophe-
nol, 2,3,5,6-tetrafluorophenol, 2,5-dinitrophenol and 2-nitrophenol, using ammonium 
acetate and ammonium bicarbonate buffers in pH range 8.5–10 with Epic FO-LB col-
umn. The column dead time was 1.2 min. 
 
For protonated acids (HA, pKa above 10), the mobile phase pH did not have a 
strong influence on the retention time in the case when ammonium acetate was 
used for all acids included in the study (Fig. 23). In case of ammonium bicar-
bonate, the retention decreased with the increase of the pH for all protonated 
acids included in the study. For deprotonated bases (B, pKa below 7), the reten-
tion time decreased for all compounds with ammonium acetate and ammonium 




Figure 23. Retention times (n = 3) of protonated acid, AH-3-nitroaniline and deproto-
nated base B-2-methylpyridine, using ammonium acetate and ammonium bicarbonate 






The retention of protonated bases (BH+) was stronger on alkyl perfluorinated 
C8, increasing k values for all analytes. The change in retention was the strong-
est in the case of diisopropylamine and the k increased approximately 30–40 
times. In the case of piperidine, the change on retention was also remarkable  
(k was 4.6 times higher on pH 10 for using ammonium acetate buffer) while the 
change of retention for pyrrolidine and diethylamine was also significant 
(change of k was approximately in the range of 40–50 times) (Fig. 17 and  
Fig. 21). 
Interestingly, regarding the retention of deprotonated acids, A− was signifi-
cantly shorter retention time on alkyl perfluorinated C8 phase. For all the ana-
lytes, the k was higher using the C18 column, with one exception 2-nitrophenol 
at pH 8.5 having k value about 2 times higher on the fluorinated stationary 
phase.  
For neutral analytes (protonated acids, HA and deprotonated bases, B)  
(Fig. 23), the retention factor did not change the k value significantly for  
3-nitroaniline (represents protonated bases), which were 5.4 and 5.6 for C18 
and fluorinated C8 stationary phases using ammonium acetate. For 
deprotonated bases, the retention decreased with the increase of pH on both 
stationay phases – C18 and fluorinated C8. The same decrease in retention was 
observed when using ammonium bicarbonate for the analysis of protonated 
bases. Retention decrease with the increase of pH is explained with the 
difference of ionic strengths of the ammonium acetate buffers: more ammonium 
hydroxide solution was required to obtain buffer solutions with a higher pH 
because of higher ionic strength.  
 
 
4.7.2. Comparison of analytes’ retention on alkyl perfluorinated C8 
stationary phase with retention on C18 stationary phase using 
fluoroalcohols as buffer components 
The retention of protonated bases (BH+) was stronger on alkyl perfluorinated 
C8 compared to HFIP and HFTB in the C18 stationary phase. For all analytes, 
the retention factor k values were 1.5 to 22 times higher with alkyl perfluori-
nated C8. Retention behavior itself was completely different – while the use of 
fluorinated alcohols resulted mostly in the U-shape retention (on the buffers’ pH 
increase) of BH+ compounds, then the retention in the fluorinated stationary 
phase increased with the increase of the pH, exactly as in the C18 stationary 
phase using common buffer compounds. An exception was pyrrolidine with a 
fluorinated stationary phase, resulting in a bell-shape retention on the increase 
of pH of the mobile phase (Fig. 17 and Fig. 21). 
The retention factor of deprotonated acids (A–) was comparable with fluori-
nated alcohols in the C18 stationary phase and ammonium bicarbonate and 
ammonium acetate on the fluorinated stationary phase. For 2-nitrophenol, the k 
was slightly higher when using the fluorinated stationary phase. The trends in 
retention were completely opposite, while using HFIP and HFTB the retention 
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increased with the increase of the pH, then on the fluorinated stationary phase 
the retention decreased with the increase of the pH (Fig. 18 and Fig. 22).  
The retention of neutral analytes was similar as described in Section 4.3.2.  
The retention behavior of analytes is completely different on the fluorinated 
stationary phase compared with the C18 stationary phase and fluoroalcohols. 
Consequently, using HFIP and HFTB eluent modifiers provides alternate selec-
tivity compared to conventional C18 stationary phases, and also perfluoronated 
C18 phases. On fluorinated stationary phases, the column bleeding often occurs 
even when enhanced stationary phase binding techniques are used. Fluorinated 
stationary phases even with better pH stability are sensitive for the high pH. The 
named downsides cause problems on MS detection and contamination on the 
ESI source, or even worse – in the MS capillary. In the progress of fluorinated 
columns’ advancement, alternatively the use of the fluoroalcohols as buffer 




4.8. Applications of using fluoroalcohols as buffer 
components in LC-ESI-MS 
As shown previously (in Section 4.1.2. [III,V]), the chromatographic separation 
of pharmaceuticals having similar chemical properties or simultaneous determi-
nation of many chemically diverse substances or using complex matrix compo-
nents have been problematic. For the enhancement of the separation and de-
crease of matrix effects, fluorinated alcohols were used. 
 
 
4.8.1. Analysis of carbapenems 
Chromatographic separation of carbapenems  
In carbapenem analysis, the analyte peak symmetry and retention time are 
strongly dependent on the eluents’ pH. Carbapenems are mostly in the zwitteri-
onic form in the pH range 3.5 to 6. The peak shape and retention in this pH 
range was poor. Better peak shapes and stronger retention of meropenem and 
doripenem were observed in the pH range 7 to 10. Using traditional buffers in 
this pH range did not provide necessary separation of doripenem and ertapenem 
(Fig. 11). Therefore, the HFIP was used for elution. Using a 5 mM HFIP pH 10 
buffer and MeOH with a gradient elution, the excellent separation of five ana-
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72% (estimated at 3 concentration levels within the calibration range, triplicate 
analysis). If matrix-matched calibration was employed (carbapenems’ calibra-
tion solutions prepared in blood plasma), average recoveries for all pharmaceu-
ticals were around 100% (SD 8%) at three concentration levels within the cali-
bration range (the high, low and average concentration, 0.5 μg/mL, 20 μg/mL 
and 100 μg/mL, respectively). The method within-day accuracy and precision 
were estimated on the aforementioned three concentration levels and for LOQ, 
the values ranged from 100 ± 0.3% to 100 ± 9% and from 1.5% to 8.4%, re-
spectively, for all analytes. The between-day accuracy and precision of the 
method ranged from 100 ± 3.2% to 100 ± 7% and from 2.7% to 7.9%, respec-
tively, for all analytes. 
The LOQ and LOD values (using UV detection) were estimated as 10 times 
and 3 times, respectively, of the standard deviation from five replicate analysis 
of spiked plasma samples on low concentration, LOQ was 10 times and LOD 
was 3 times standard deviation. The LOQ values ranged from 0.4 to 1.6 μg/mL 
and LOD values from 0.1 to 0.5 μg/mL for all analytes. 
Extensive stability study for carbapenem samples and standard solutions was 
carried out and it appeared that carbapenem blood plasma samples have to be 
stored at –80 ºC after the sample collection. The long-term stability studies at  
–80 ºC for blood plasma samples showed analytes to be stable and degradation 
was approximately 4% within 3 months. Pretreated blood plasma samples 
showed degradation at room temperature – after 4 h the degradation was around 
7 to 31%, depending on the analyte. Therefore pretreated blood plasma samples 
have to be analyzed as soon as possible and for the analysis samples have to be 
stored at 4 ºC in a thermostated autosampler. In the thermostated autosampler, 
the analytes’ content of samples did not decrease significantly during 3 hours. 
 
Chromatographic separation for meropenem microanalysis [VII] 
For the microanalysis of meropenem only the method using acidic conditions 
for elution and the separation from blood plasma was successfully achieved 
(Fig. 25). Meropenem and ertapenem (I.S.) peak shapes on the low mobile 
phase pH tend to be asymmetric and the peaks are low. Although, the sample 
preparation for plasma samples with LE is quick it is also “dirty”. The content 
of blood plasma components in the injected sample is rather high leading ap-
pearance of several peaks and bands in the chromatogram [I,II,VII]. At the end 
of the chromatogram, when the content of organic solvent (MeOH) is high, a 
massive peak (using wavelength 224 nm, not used for meropenem detection) 
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Validation of the meropenem microanalysis method [VII] 
For the meropenem microanalysis method validation [152], the spiked mero-
penem plasma samples were prepared and sample preparation was performed 
separately. The calibration graphs with the peak area versus the concentration 
composed in the concentration range 0.1–200 μg/mL and from 1 to 250 μg/mL 
for urine were linear with r2>0.9999. With meropenem, the calibration in blood 
plasma average recoveries was around 100% (SD 6%) at three concentration 
levels within the calibration range (the high, low and average concentration, 2 
μg/mL, 10 μg/mL and 100 μg/mL, respectively) and for LOQ. The method 
within-day accuracy and precision were determined at the abovementioned con-
centration levels and were 100 ± 4% and 100 ± 6%, respectively, for all ana-
lytes. The method between-day accuracy and precision were 4% and 8%, re-
spectively. Meropenem sample preparation and stability have been discussed 
previously [II]. As other carbapenems meropenem blood plasma and urine sam-
ples have to be analyzed as soon as possible and for the analysis samples have 
to be stored at 4 ºC in a thermostated autosampler. LOQ for plasma samples 
was 0.1 µg/mL and LOD 0.01 µg/mL. LOQ for urine samples as the lowest 
concentration of calibration samples was 1 µg/mL with accuracy 100 ± 3% and 
precision (as coefficient of variation) < 2%. 
 
 
4.8.1. FQs and SAs in plants 
LC procedure for the plant samples 
For a better chromatographic separation, the fluorinated stationary phase was 
used for the antibiotic standard solution with the elution with AAF at pH 2.8 
(Table 3) (Fig. 29). 
 
 
Figure 29. UV chromatogram of the standard solution of FQs and SAs. Eluent: AAF (pH 2.8) 
and MeOH. Used analytical column: Epic FO-LB C8 column (150 mm × 3 mm, 3.5 μm). 
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Reputedly, retention of fluorinated compounds is enhanced on fluorous station-
ary phases [46]. The separation of antibiotics was achieved on the alkyl 
perfluorinated stationary phase, with low FQs peaks were recorded. Fluorinated 
analytes retention on the fluorinated stationary phase is mainly influenced by 
the amount on fluorine atoms in the analyte molecule [46]. The number of fluo-
rine atoms in the three FQs studied is one and the structures of the molecules 
are similar, therefore the retention of the analytes on fluorinated stationary 
phase is also similar. On the other hand the ESI signal of the analytes should be 
enhanced on the acidic conditions (see on Section 4.1.2). The MS chromato-
gram of the FQs and SAs separation had high noise level in extracted ion chro-
matograms for FQs, the peaks were broad and partly overlapping (Fig. 30). 
Neither better of the separation nor enhanced signal were obtained by optimiza-
tion of the elution gradient nor the buffer composition or pH.  
  
 
Figure 30. MS chromatogram of the standard solution of FQs’ and SAs’ (10 µg/mL). 
Eluent: AAF (pH 2.8) and MeOH. Used analytical column: Epic FO-LB C8 column 
(150 mm × 3 mm, 3.5 μm). 
 
A successful chromatographic separation of five antibiotics in plant samples 
was demonstrated in paper V. The successful separation and better peak shapes 
of the antibiotics was achieved using either fluoroalcohols – HFIP or HFTB. 
For the LC analysis the 5 mM HFIP and gradient elution with methanol was 
used. Application demonstrates the successful separation of chosen compounds 




Figure 31. The chromatographic separation antibiotic residues in potato tubers, grown in 
sandy soil at the antibiotic soil concentration of 10 mg/kg. Eluent: 5 mM HFIP (pH 9) and 
MeOH. Used analytical column: Waters XBridge C18 column (150 mm × 3 mm, 3.5 μm). 
 
Method validation for the plant samples  
The method described above was validated for the simultaneous determination 
of CIP, NOR, OFL, SDM, and SMX from plants. For calibration antibiotics 
standard solutions were prepared in an eluent (5 mM HFIP and 10% methanol). 
The calibration graphs with the peak area versus the concentration were com-
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posed in the concentration range 1–10,000 ng/mL and were linear with 
r2>0.9998. Recovery was calculated from standard addition experiments. Re-
coveries for all detected pharmaceuticals in all matrices varied from 54 to 98%, 
the average recoveries are shown in Table 6. 
 
Table 6. Average recoveries for the parts of the analyzed plants.  
Average recoveries (n = 2) 
Sample matrix Loamy soil 
Carrot leaves 81% 
Carrot roots 66% 
Wheat leaves 93% 
Wheat seeds 91% 
Lettuce leaves 92% 
Lettuce roots 93% 
Potato tubers 87% 
 
The difference in the sample preparation recoveries for the plants grown in two 
soils was not significant. The lowest recoveries were observed for the carrot 
root samples grown on loamy soil and this sample matrix was selected for the 




Figure 32. Sample preparation recoveries for the carrot root samples grown in loamy 
soil (n = 5).  
 
Antibiotic recovery ranged from 55–76% for the carrot root samples with the 
standard deviation of 1% for SMX, SDM and CIP and 2% for NOR and OFL. 
The LOQ and LOD values were estimated, respectively, as 10 times and 3 times 
the standard deviation of five replicate analysis of unspiked and spiked plant 
samples. The LOQ values were as follows: CIP 0.11; NOR 0.16; OFL 0.02; 
SDM 0.07 and SMX 0.13 µg/g and LOD values CIP 0.03; NOR 0.05; OFL 




The aim of the present work was to study the suitability and usage of two 
fluoroalcohols as volatile buffer compounds for HPLC-ESI-MS analysis.  
HFIP and HFTB were evaluated as buffer components for basic mobile 
phases (pH 8.5 to 10) for RP chromatography with ESI-MS detection. Chro-
matographic separation and ESI ionization efficiency in positive and negative 
modes were evaluated for the selected five antibiotics using the novel buffer 
additives and in comparison to the commonly used buffers. The best chromato-
graphic separation and most intense ESI-MS signals were obtained with buffers 
based on either HFIP or HFTB (5 mM of fluoroalcohol, pH adjusted to pH 9.0 
with ammonium hydroxide) and methanol as the organic modifier. 
Fluoroalcohols, HFIP and HFTB, can be used as buffer additives for basic 
LC-ESI-MS-compatible eluents suitable for the separation of acidic and basic 
compounds. HFIP and HFTB as buffer additives result in the complex RP re-
tention behavior of analytes. All trends in the retention of the acidic and basic 
analytes can be interpreted by considering the following: hydrophobi-
city/hydrophilicity of the analytes in terms of their acid-base properties; the 
neutral fluoroalcohols are strongly retained by the stationary phase whereas 
their anions are less retained, thus their amount on the stationary phase is de-
pendent on the mobile phase pH; the anions of the fluoroalcohols form ion pairs 
with protonated basic analytes in the mobile phase, thereby favoring their re-
tention; the fluoroalcohols on the stationary phase surface compete with acidic 
analytes, thereby hindering their retention.  
The retention of acids and bases on the C18 stationary phases with different 
hydrophobicities were evaluated and the dependence on the buffer compound 
and stationary phase properties were noted – the complex retention behavior of 
analytes caused provided by the usage of the fluorinated alcohol is dependent 
on the stationary phase because of the competition of fluorinated alcohols and 
analytes.  
The retention of acids and bases on the fluorinated stationary phase was 
compared with the retention of the same analytes on the C18 stationary phase 
using fluorinated alcohols. Overall, the retention time on the fluorinated station-
ary phase was shorter than the retention on the C18 stationary phase. The alkyl 
perfluorinated stationary phase is noted to be useful for its ability to enable the 
successful separation of halogenated compounds. However, the successful sepa-
ration of 3 FQs was achieved using HFIP and HFTB buffers and the C18 sta-
tionary phase. The similar structure (and content of fluorine atoms in the mole-
cule) of FQs resulted in poor separation on the perfluorinated stationary phase. 
Neither was the separation satisfactory on the C18 stationary phase without the 
HFIP or HFTB buffer. Consequently, HFIP and HFTB buffers in the C18 col-
umn provide alternative selectivity compared to the perfluorinated and C18 
stationary phase with common buffers. 
The usefulness of HFIP and HFTB as buffer compounds for LC-ESI-MS 
analysis was demonstrated with several practical examples. The validated 
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methods of analysis of antibiotic (FQs and SAs) residues in plants and the suc-
cessful separation of carbapenems in blood plasma and urine samples are pre-
sented. 
The results of the study about fluoroalcohols demonstrate the benefits of 
their usage as LC-ESI-MS buffer compounds for basic buffer solutions. The 
alternative retention enables a higher selectivity of the chromatographic separa-
tion. The currently rather limited range of ESI-compatible buffer systems for 







SUMMARY IN ESTONIAN 
Fluoroalkoholid LC-ESI-MS eluendi komponendina:  
kasutatavus ja rakendused 
 
Ravimite määramine vedelikkromatograafilisel (LC) massispektromeetrilisel 
(MS) meetodil kasutades elektropihustusionisatsiooni (ESI) leiab järjest laiemat 
kasutust. Ravimite pöördfaasvedelikkromatograafiliseks lahutamiseks kasuta-
takse sagedasti happelist puhverlahust, mis tähendab aga, et ravimid kui pea-
miselt aluselised ühendid on analüüsil protoneeritud ehk hüdrofiilsed. Hüdro-
fiilsetel ainetel aga on pöördfaaskromatograafias nõrk retentsioon. Aluseliste 
ühendite vedelikkromatograafiliseks lahutamiseks oleks parem kasutada aluse-
list keskkonda. 
LC-MS seab kasutatavatele eluentidele lenduvuse nõude, mis omakorda 
vähendab kasutatavate aluseliste puhverlahuste valikut. Teine oluline omadus, 
mida peab LC-ESI-MS puhverlahuse valimisel silmas pidama, on analüütide 
ionisatsioon – puhverlahuse komponendid ei tohi analüüdi ionisatsiooni maha 
suruda. 
Üheks paljulubavaks ainete klassiks, mis võimaldaks aluseliste puhver-
lahuste valikut suurendada, on fluoroalkoholid. Lenduvate aluseliste puhver-
lahuste valiku laiendamiseks uuriti fluoroalkoholide – 1,1,1,3,3,3-heksfluoro-2-
propanooli (HFIP) ja 1,1,1,3,3,3-heksafluoro-2-metüül-2-propanooli (HFTB) 
kasutusvõimalusi LC-MS aluseliste puhverlahustena.  
HFIP ja HFTB kui nõrkade hapete omadusi hinnati aluseliste puhverlahuste 
kasutamiseks pöördfaaskromatograafiliseks analüüsiks, kui detektorina on kasu-
tusel MS. Töö käigus uuriti viie antibiootikumi pöördfaasvedelikkromatograa-
filist lahutust ning ioniseerumist nii positiivses kui ka negatiivses režiimis, kui 
HFIP ja HFTB on kasutusel LC-ESI-MSi eluendi komponendina ning saadud 
tulemusi võrreldi traditsiooniliste eluentidega. Mõlemad fluoroalkoholid aitasid 
kaasa analüütide ioniseerumisele ning ainetele, mis tavapäraste eluentidega 
kromatograafiliselt ei lahutunud, saavutati suurepärane lahutus.  
HFIP ja HFTB kasutamisel pöördfaaskromatograafiliseks analüütide lahuta-
miseks on ainete retentsioonimehhanismid keerukad, kuid just see võimaldabki 
ainetele alternatiivset LC eraldust. Protoneeritud fluoroalkoholid kinnituvad 
tugevalt statsionaarse faasi pinnale, samas kui deprotoneeritult on nende re-
tentsioon tunduvalt nõrgem. Deprotoneeritud fluoroalkoholid on võimelised 
moodustama ioonpaare protoneeritud aluseliste analüütidega, mis omakorda 
suurendab ioonpaardunud analüütide retentsiooni. Üldiselt vähendavad fluoro-
alkoholid happeliste ühendite retentsiooni konkureerides analüütidega statsio-
naarse faasi pinna pärast ning suurendavad aluste retentsiooni, kuna on võime-
lised moodustama ioonpaare. Kuna konkurentsi- ja ioonpaarmehhanismid toi-





Fluoroalkoholide kasutamist võrreldi ka erinevate hüdrofoobsustega C18 
statsionaarsete faasidega. Analüütide retentsioon sõltub suuresti ka statsio-
naarsest faasist, kuna hüdrofoobsemal statsionaarse faasi pinnal on ka tugevam 
analüüdi ning puhvri komponendi konkurents.  
Fluoreeritud statsionaarse faasi kasutamine on üheks alternatiiviks paran-
damaks analüütide retentsiooni. Fluoreeritud statsionaarse faasi kasutamisega 
vähenesid kõikide analüütide retentsiooniajad võrreldes tavapärase C18 statsio-
naarse faasi kasutamisega. Fluoreeritud statsionaarsed faasid omavad teada-
olevalt alternatiivset analüütide lahutamisvõimalust, kuna halogeeniaatomeid 
sisaldavad analüüdid kinnituvad tugevamalt statsionaarse faasi pinnale. Fluoro-
kinoloonide jaoks saavutati edukas lahutus HFIPi ning HFTBga, kui statsio-
naarse faasina oli kasutusel C18. Fluoreeritud statsionaarne faas ei võimaldanud 
kõiki antud ühendeid lahutada, samuti ei võimaldanud seda tavapärane C18 
kolonn ilma fluoroalkohole kasutamata. Seega pakuvad HFIP ja HFTB alter-
natiivset selektiivsust C18 statsionaarsele faasile analüütide lahutamiseks levi-
nud puhverlahustega ning fluoreeritud statsionaarse faasiga.  
HFIP ja HFTB kasutusvõimalusi LC-ESI-MS analüüsil demonstreeriti mit-
me praktilise näite varal ja välja töötatud metoodikad valideeriti – fluoro-
kinoloonide ja sulfoonamiidide jääke määrati taimeproovidest, karbapeneeme 
määrati inimese verest ning uriinist.  
Fluoroalkoholide LC-ESI-MS puhverlahuste komponentidena aluseliste puh-
verlahuste valmistamisel kasutamine omab mitmeid väljatoodud eeliseid. Fluo-
roalkoholid pakuvad alternatiivset retentsioonimehhanismi analüütide paremaks 
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